Profiles

Bruce Taylor

UTAS Home › Prof Bruce Taylor

Bruce Taylor

Professorial Research Fellow
Menzies Institute for Medical Research

Hobart CBD Campuses

+61 3 6226 7765 (phone)

Bruce.Taylor@utas.edu.au

Multiple Sclerosis (MS) is a disease of the central nervous system that affects motor, sensory and cognitive functions. It affects approximately 23,000 Australians, and Tasmanians are seven times more likely to develop it than people living in northern areas like Cairns. Clinical neuroscientist, Professor Bruce Taylor, is working out why.

Unlocking the secrets of the sun

A team of researchers in Tasmania is leading the world in determining the population risk factors for multiple sclerosis. And they need to be. Tasmanians are more likely to develop the disease than people living anywhere else in Australia, and there is no cure.

'MS is a multifactorial illness, which means there is no one cause. A number of factors have been found to contribute including genetics, the environment, responses to common viral triggers, body mass index and smoking.'

'Understanding how these factors interact could help prevent the disease. And we are starting to piece together the puzzle,' said Professor Taylor.

Professor Taylor's research has helped uncover a direct link between sun exposure and MS.

'We now know that attacks of MS are related to low levels of vitamin D. This explains why the disease is so common in Tasmania and other destinations located at a similar distance from the equator.'

'We have also found that cases in environments with different latitudinal gradients can be attributed to genetic factors that inhibit the metabolism of vitamin D.'

The relationship between vitamin D, latitude and sunlight is a significant discovery. It provides the basis for further research into the prevention of MS as well as other diseases.

'A large population study using vitamin D supplements over 20 years could provide incredible insights. Vitamin D might be a factor in other diseases as well,' said Professor Taylor.

Professor Taylor is Chairman of the Australian MS Clinical Research Network directing studies into this puzzling disease. He also sits on the steering committee of the International MS Genetics Consortium. But he says that Tasmania is a perfect place to study the disease.

'Tasmania has a stable and relatively isolated population, and the research participation rate from the Tasmanian community is incredible. Tasmanians want to find a way to slow the progression of this disease, and they want to prevent their children from developing it.'

'MS progresses faster in some people than others and we still don't know why. I am interested in what we can do to intervene, for example, studying the impact of giving vitamin D supplements at the first signs of MS.'

While Professor Taylor's research is concerned with how to slow the progression of the disease, the ultimate goal is to prevent the onset of MS.

'If we could identify the risk factors and reduce them by just 50%, we could potentially stop 2.5 million cases of MS globally.'

By discovering the importance of vitamin D, Professor Taylor and his colleagues are now one step closer.

Bruce Taylor is Professor of Neurological Research University of Tasmania. In 2007 he was appointed as a principal research fellow at the Menzies Institute for Medical Research in Hobart as a 50/50 conjoint position with the Royal Hobart Hospital. Since taking up this position in July 2007, he has established the ongoing Tasmanian Genes and Prevalence study, become an executive member of the Australian & New Zealand MS genes consortium (ANZGENE) funded by MS research Australia and an ARC linkage grant, established the NHMRC funded AUSLONG and AUSLONG2 studies, become an executive member of the Australian & New Zealand NMO study, become a steering committee member of the international MS genetic consortium, and established and obtained funding for the PREvention of MS with Vitamin D Australia & New Zealand (PREVANZ) study funded by MS research Australia ($3.5 million).

Biography

Prof Taylor is medical graduate of the University of Tasmania and completed specialist training in Neurology in Western Australia and at the Mayo Clinic USA, returning to Australia in 1996 to begin clinical practice in Neurology in Hobart Tasmania. In 2000 he completed and was awarded an MD from the University of Tasmania in the field of peripheral nerve disease with a focus on multifocal motor neuropathy. In 2004 Prof Taylor accepted his first academic appointment as Associate Professor and Neurologist at the Christchurch School of Medicine University of Otago, New Zealand. Whilst in New Zealand he established the New Zealand MS research interest group and was the Primary Investigator on the NZ HRC funded 'National prevalence study of MS in NZ'.

View more on Professor Bruce Taylor in WARP

Research Themes

Prof Taylor's research interests align with one of the University's key research themes of Better Health. His principal areas of research interest are in the field of MS epidemiology including the personal, clinical and genetic factors that are associated with the onset and progression of MS. This involves the development of complex cohort studies and gene environment interaction studies. This body of research has resulted in a unique set of research skills, including significant experience in the development of large multicentre cohort studies of MS as well as significant experience in clinical and genetic MS research. One of the most crucial translations of Prof Taylor's research has been the direct uptake of Vitamin D by significant numbers of MS patients in Australia and overseas.

Awards

Lifetime achievement award for service to people with MS, Tasmanian MS society, 2005.

Fields of Research

  • Central nervous system (320903)
  • Neurology and neuromuscular diseases (320905)
  • Epidemiology (420299)
  • Health economics (380108)
  • Peripheral nervous system (320906)
  • Medical genetics (excl. cancer genetics) (320213)
  • Neurogenetics (310511)
  • Cellular nervous system (320902)
  • Mental health services (420313)
  • Health psychology (520304)
  • Health promotion (420603)
  • Genetics (310599)
  • Health informatics and information systems (420308)
  • Rehabilitation (420109)
  • Genomics (310509)
  • Preventative health care (420605)
  • Clinical sciences (320299)
  • Immunology (320499)
  • Autoimmunity (320403)
  • Health services and systems (420399)
  • Environmental epidemiology (420203)
  • Neurosciences (320999)
  • Infectious diseases (320211)
  • Cellular immunology (320404)
  • Public health (420699)
  • Immunogenetics (incl. genetic immunology) (320406)
  • Proteins and peptides (340407)
  • Biological adaptation (310403)
  • Autonomic nervous system (320901)
  • Gene mapping (310506)
  • Sensory systems (320907)
  • Nutritional science (321004)
  • Innate immunity (320407)
  • Statistical and quantitative genetics (310207)
  • Behavioural neuroscience (520202)
  • Sport and exercise nutrition (321006)
  • Nursing (420599)
  • Health and community services (420305)
  • Probability theory (490506)
  • Bioassays (340102)
  • Implementation science and evaluation (420312)
  • Behavioural epidemiology (420201)
  • Nutrition and dietetics (321099)
  • Medical microbiology (320799)
  • Medicine, nursing and health curriculum and pedagogy (390110)
  • Translational and applied bioinformatics (310208)
  • Epigenetics (incl. genome methylation and epigenomics) (310504)
  • Health policy (440706)
  • Disease surveillance (420202)
  • Anaesthesiology (320201)
  • Endocrinology (320208)
  • Motor control (420703)
  • Basic pharmacology (321401)
  • Digital health (420302)
  • Traditional, complementary and integrative medicine (420899)
  • Systems physiology (320803)
  • Clinical pharmacology and therapeutics (321402)
  • Educational technology and computing (390405)
  • Social epidemiology (420210)
  • Biologically active molecules (340401)
  • Health management (420309)
  • Cardiology (incl. cardiovascular diseases) (320101)
  • Cell physiology (320801)
  • Cell and nuclear division (310502)
  • Tumour immunology (320409)
  • Pharmacology and pharmaceutical sciences (321499)
  • Medical physiology (320899)
  • Gene expression (incl. microarray and other genome-wide approaches) (310505)
  • Regenerative medicine (incl. stem cells) (320606)
  • People with disability (420318)
  • Ophthalmology (321201)

Research Objectives

  • Clinical health (200199)
  • Preventive medicine (200412)
  • Evaluation of health outcomes (200202)
  • Treatment of human diseases and conditions (200105)
  • Public health (excl. specific population health) (200499)
  • Diagnosis of human diseases and conditions (200101)
  • Expanding knowledge in the biomedical and clinical sciences (280103)
  • Prevention of human diseases and conditions (200104)
  • Disease distribution and transmission (incl. surveillance and response) (200404)
  • Mental health (200409)
  • Health education and promotion (200203)
  • Other health (209999)
  • Expanding knowledge in the health sciences (280112)
  • Expanding knowledge in the biological sciences (280102)
  • Behaviour and health (200401)
  • Specific population health (excl. Indigenous health) (200599)
  • Health policy evaluation (200205)
  • Determinants of health (200201)
  • Health status (incl. wellbeing) (200407)
  • Health system performance (incl. effectiveness of programs) (200206)
  • Nutrition (200410)
  • Efficacy of medications (200102)
  • Allied health therapies (excl. mental health services) (200301)
  • Other economic framework (159999)
  • Expanding knowledge in economics (280108)
  • Human pharmaceutical treatments (240803)
  • Carbon and emissions trading (159901)
  • Human biological preventatives (240801)
  • Nursing (200307)
  • Human diagnostics (240802)
  • Health inequalities (200204)
  • Expanding knowledge in psychology (280121)
  • Evaluation of health and support services (200299)
  • Disability and functional capacity (200403)
  • Injury prevention and control (200408)
  • Human pharmaceutical products (240899)
  • Information services (220399)
  • Social structure and health (200207)

Publications

Total publications

340

Journal Article

(287 outputs)
YearCitationAltmetrics
2023Campbell JA, van der Mei I, Taylor BV, Palmer AJ, Henson GJ, et al., 'Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels', Journal of Neurology, Neurosurgery and Psychiatry ISSN 0022-3050 (2023) [Refereed Article]

[eCite] [Details]

Co-authors: Campbell JA; van der Mei I; Palmer AJ; Henson GJ; Laslett LL; Simpson-Yap S; Claflin SB

2023Claflin SB, Campbell J, Taylor BV, 'Healthcare utilisation and perceived healthcare accessibility and quality among people living with multiple sclerosis enrolled in an online course', Multiple Sclerosis and Related Disorders, 73 pp. 1-7. ISSN 2211-0348 (2023) [Refereed Article]

DOI: 10.1016/j.msard.2023.104621 [eCite] [Details]

Co-authors: Claflin SB; Campbell J

Tweet

2023Claflin SB, Campbell J, van der Mei I, Mainsbridge C, Taylor BV, 'Self-reported behaviour change among multiple sclerosis community members and interested laypeople 6 months following participation in a free online course about multiple sclerosis', Health Promotion Journal of Australia pp. 1-10. ISSN 2201-1617 (2023) [Refereed Article]

DOI: 10.1002/hpja.716 [eCite] [Details]

Co-authors: Claflin SB; Campbell J; van der Mei I; Mainsbridge C

Tweet

2022Bessing B, Claflin SB, Taylor BV, Blizzard L, Honan CA, et al., 'Estimating the impact of work difficulties, work self-efficacy and work psychological safety on MS-related work productivity loss', Multiple Sclerosis pp. 1-14. ISSN 1352-4585 (2022) [Contribution to Refereed Journal]

DOI: 10.1177/13524585221097573 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Bessing B; Claflin SB; Blizzard L; Honan CA; van der Mei I

Tweet

2022Bessing B, Honan C, van der Mei I, Taylor BV, Claflin SB, 'Measurement properties of the Health Literacy Questionnaire in the Understanding Multiple Sclerosis Massive Open Online Course Cohort: A Rasch analysis', Health Literacy Research and Practice, 6, (3) pp. e200-e212. ISSN 2474-8307 (2022) [Refereed Article]

DOI: 10.3928/24748307-20220720-01 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Bessing B; Honan C; van der Mei I; Claflin SB

Tweet

2022Bessing B, van der Mei I, Taylor BVM, Honan CA, Blizzard L, et al., 'Evaluating the impact of the Understanding Multiple Sclerosis online course on participant MS knowledge, health literacy, resilience, self-efficacy, quality of life, and MS symptom severity', Multiple Sclerosis and Related Disorders, 60 Article 103717. ISSN 2211-0356 (2022) [Refereed Article]

DOI: 10.1016/j.msard.2022.103717 [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Co-authors: Bessing B; van der Mei I; Honan CA; Blizzard L; Claflin SB

Tweet

2022Campbell JA, Ahmad H, Chen G, van der Mei I, Taylor B, et al., 'Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia', Quality of Life Research ISSN 0962-9343 (2022) [Refereed Article]

DOI: 10.1007/s11136-022-03214-y [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Campbell JA; Ahmad H; van der Mei I; Claflin S; Henson GJ; Laslett L; Hawkes K; Hurst C; Waugh H; Palmer AJ

Tweet

2022Claflin S, Campbell JA, Norman R, Mason DF, Kalincik T, et al., 'Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand', The European Journal of Health Economics Article ePub ahead of print. ISSN 1618-7598 (2022) [Refereed Article]

DOI: 10.1007/s10198-022-01518-x [eCite] [Details]

Co-authors: Claflin S; Campbell JA; Simpson-Yap S; Palmer AJ; Blizzard CL; van der Mei I; Henson GJ

Tweet

2022Claflin SB, Klekociuk S, Fair H, Bostock E, Farrow M, et al., 'Assessing the impact of online health education interventions from 2010-2020: A systematic review of the evidence', American Journal of Health Promotion, 36, (1) pp. 201-224. ISSN 0890-1171 (2022) [Refereed Article]

DOI: 10.1177/08901171211039308 [eCite] [Details]

Citations: Scopus - 7Web of Science - 6

Co-authors: Claflin SB; Klekociuk S; Fair H; Bostock E; Farrow M; Doherty K

Tweet

2022Fortune AJ, Taylor BV, Charlesworth JC, Burdon KP, Blackburn NB, et al., 'Generation and characterisation of four multiple sclerosis iPSC lines from a single family', Stem Cell Research, 62 Article 102828. ISSN 1873-5061 (2022) [Refereed Article]

DOI: 10.1016/j.scr.2022.102828 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Fortune AJ; Charlesworth JC; Burdon KP; Blackburn NB; Fletcher JL; Mehta A; Young KM

Tweet

2022Fuh-Ngwa V, Zhou Y, Melton PE, van der Mei I, Charlesworth JC, et al., 'Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis', Scientific Reports, 12, (1) pp. 1-13. ISSN 2045-2322 (2022) [Refereed Article]

DOI: 10.1038/s41598-022-23685-w [eCite] [Details]

Co-authors: Fuh-Ngwa V; Zhou Y; Melton PE; van der Mei I; Charlesworth JC; Lin X; Zarghami A

Tweet

2022Henson GJ, Taylor BV, van der Mei I, Claflin SB, Simpson-Yap S, et al., 'Protocol for a systematic review and meta-analysis of minimal important differences for generic multiattribute utility instruments', BMJ Open, 12, (10) Article e062703. ISSN 2044-6055 (2022) [Refereed Article]

DOI: 10.1136/bmjopen-2022-062703 [eCite] [Details]

Co-authors: Henson GJ; van der Mei I; Claflin SB; Palmer AJ; Xia Q; Antony B; Singh Ambrish; Campbell JA

Tweet

2022Laslett LL, Honan C, Turner JA, Dagnew B, Campbell JA, et al., 'Poor sleep and multiple sclerosis: associations with symptoms of multiple sclerosis and quality of life', Journal of Neurology Neurosurgery and Psychiatry, 93 pp. 1162-1165. ISSN 0022-3050 (2022) [Refereed Article]

DOI: 10.1136/jnnp-2022-329227 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Laslett LL; Honan C; Turner JA; Campbell JA; Blizzard L; van der Mei I

Tweet

2022Lin X, Yang Y, Gresle M, Cuellar-Partida G, Han X, et al., 'Novel plasma and brain proteins that are implicated in multiple sclerosis', Brain ISSN 0006-8950 (2022) [Refereed Article]

DOI: 10.1093/brain/awac420 [eCite] [Details]

Co-authors: Lin X; Simpson-Yap S; Fuh-Ngwa V; Charlesworth JC; Burdon KP; Zhou Y

Tweet

2022Lin Xin, Yuanhao Y, Melton PE, Singh V, Simpson-Yap S, et al., 'Integrating Genetic structural variations and whole genome sequencing into clinical neurology', Neurology: Genetics, 8, (4) Article e200005. ISSN 2376-7839 (2022) [Refereed Article]

DOI: 10.1212/NXG.0000000000200005 [eCite] [Details]

Citations: Web of Science - 2

Co-authors: Lin Xin; Melton PE; Singh V; Simpson-Yap S; Burdon KP; Zhou Y

Tweet

2022Makowiecki K, Stevens N, Cullen CL, Zarghami A, Nguyen PT, et al., 'Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial', Trials, 23, (1) Article 626. ISSN 1745-6215 (2022) [Refereed Article]

DOI: 10.1186/s13063-022-06526-z [eCite] [Details]

Co-authors: Makowiecki K; Stevens N; Cullen CL; Zarghami A; Nguyen PT; Johnson L; Hinder MR; Young KM

Tweet

2022Simpson-Yap S, Atvars R, Blizzard L, van der Mei I, Taylor BV, 'Increasing incidence and prevalence of multiple sclerosis in the Greater Hobart cohort of Tasmania, Australia', Journal of Neurology, Neurosurgery and Psychiatry, 93, (7) pp. 723-731. ISSN 0022-3050 (2022) [Refereed Article]

DOI: 10.1136/jnnp-2022-328932 [eCite] [Details]

Citations: Scopus - 5Web of Science - 4

Co-authors: Simpson-Yap S; Blizzard L; van der Mei I

Tweet

2022Southam K, de Sousa C, Daniel A, Taylor BV, Foa L, et al., 'Development and characterisation of a rat model that exhibits both metabolic dysfunction and neurodegeneration seen in type 2 diabetes', Journal of Physiology, 600, (7) pp. 1611-1630. ISSN 0022-3751 (2022) [Refereed Article]

DOI: 10.1113/JP282454 [eCite] [Details]

Co-authors: Southam K; de Sousa C; Daniel A; Foa L; Premilovac D

Tweet

2022Tao C, Simpson-Yap S, Taylor B, Blizzard L, Lucas R, et al., 'Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression', Multiple Sclerosis and Related Disorders, 59 Article 103561. ISSN 2211-0356 (2022) [Refereed Article]

DOI: 10.1016/j.msard.2022.103561 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Co-authors: Simpson-Yap S; Blizzard L; van der Mei I

Tweet

2022Zarghami A, Hussain MA, Campbell JA, Ezegbe C, van der Mei I, et al., 'Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review', Multiple Sclerosis and Related Disorders, 59, (103562) pp. 3-14. ISSN 2211-0356 (2022) [Refereed Article]

DOI: 10.1016/j.msard.2022.103562 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Zarghami A; Hussain MA; Campbell JA; Ezegbe C; van der Mei I; Claflin SB

Tweet

2022Zarghami A, van der Mei I, Hussain MA, Claflin S, Bessing B, et al., 'Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination', Multiple Sclerosis, 28, (11) pp. 1793-1807. ISSN 1352-4585 (2022) [Refereed Article]

DOI: 10.1177/13524585221089900 [eCite] [Details]

Co-authors: Zarghami A; van der Mei I; Hussain MA; Claflin S; Bessing B; Simpson-Yap S; Blizzard L

Tweet

2021Ahmad H, van der Mei I, Taylor BVM, Zhao T, Xia Q, et al., 'Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis?', Multiple Sclerosis and Related Disorders, 54 pp. 1-8. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103138 [eCite] [Details]

Co-authors: Ahmad H; van der Mei I; Zhao T; Xia Q; Palmer AJ

Tweet

2021Beecher G, Shelly S, Dyck PJB, Mauermann ML, Martinez-Thompson JM, et al., 'Pure motor onset and IgM-Gammopathy occurrence in multifocal acquired demyelinating sensory and motor neuropathy', Neurology, 97, (14) pp. 1-12. ISSN 0028-3878 (2021) [Refereed Article]

DOI: 10.1212/WNL.0000000000012618 [eCite] [Details]

Citations: Web of Science - 1

Tweet

2021Bessing B, Hussain MA, Claflin SB, Chen J, Blizzard L, et al., 'Changes in multiple sclerosis symptoms are associated with changes in work productivity of people living with multiple sclerosis', Multiple Sclerosis Journal Article ePub ahead of print. ISSN 1352-4585 (2021) [Refereed Article]

DOI: 10.1177/1352458521994557 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Bessing B; Hussain MA; Claflin SB; Chen J; Blizzard L; van der Mei I

Tweet

2021Bessing B, Hussain MA, Claflin SB, Chen J, Blizzard L, et al., 'Work productivity trajectories of Australians living with multiple sclerosis: A group-based modelling approach', Multiple Sclerosis and Related Disorders, 54 Article online ahead of print. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103131 [eCite] [Details]

Citations: Scopus - 9Web of Science - 8

Co-authors: Bessing B; Hussain MA; Claflin SB; Chen J; Blizzard L; van der Mei I

Tweet

2021Bukhari W, Khalilidehkordi E, Mason DF, Barnett MH, Taylor BVM, et al., 'NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand', Journal of Neurology ISSN 0340-5354 (2021) [Refereed Article]

DOI: 10.1007/s00415-021-10665-9 [eCite] [Details]

Citations: Scopus - 4Web of Science - 5

Co-authors: Stankovich J

Tweet

2021Campbell J, Shaw SN, Mainsbridge C, Taylor BVM, Claflin SB, 'An exploratory study regarding communication facilitators and barriers reported by a cohort of multiple sclerosis (MS) community members from the international massive open online course Understanding MS'', Multiple Sclerosis and Related Disorders Article 103473. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103473 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Campbell J; Mainsbridge C; Claflin SB

Tweet

2021Chen J, Ahmad H, Taylor B, Palmer AJ, van der Mei I, 'Impact of remoteness on patient outcomes for people with multiple sclerosis in Australia', Multiple Sclerosis and Related Disorders, 55 Article 103208. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103208 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Ahmad H; Palmer AJ; van der Mei I

Tweet

2021Claflin S, Klekociuk S, Campbell JA, Bessing B, Palmer AJ, et al., 'Association between MS-related knowledge, health literacy, self-efficacy, resilience, and quality of life in a large cohort of MS community members: A cross-sectional study', Multiple Sclerosis and Related Disorders, 54 pp. 1-10. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103158 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Claflin S; Klekociuk S; Campbell JA; Bessing B; Palmer AJ; van der Mei IAF

Tweet

2021Claflin SB, Campbell JA, Doherty K, Farrow M, Bessing B, et al., 'Evaluating course completion, appropriateness and burden in the Understanding Multiple Sclerosis massive open online course: a cohort study', Journal of Medical Internet Research ISSN 1439-4456 (2021) [Refereed Article]

[eCite] [Details]

Co-authors: Claflin SB; Campbell JA; Doherty K; Farrow M; Bessing B

2021Claflin SB, Campbell JA, Mason DF, Kalincik T, Simpson-Yap S, et al., 'The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis', Multiple Sclerosis Article online ahead of publication. ISSN 1352-4585 (2021) [Refereed Article]

DOI: 10.1177/13524585211035948 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Co-authors: Claflin SB; Campbell JA; Simpson-Yap S; Palmer AJ; Blizzard CL; van der Mei I

Tweet

2021Claflin SB, Mainsbridge C, Campbell J, Klekociuk S, Taylor BVM, 'Self-reported behaviour change among multiple sclerosis community members and interested laypeople following participation in a free online course about multiple sclerosis', Health Promotion Journal of Australia ISSN 2201-1617 (2021) [Refereed Article]

DOI: 10.1002/hpja.559 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Claflin SB; Mainsbridge C; Campbell J; Klekociuk S

Tweet

2021Claflin SB, Zhou Y, Taylor BVM, van der Mei I, 'Assessing the consistency and validity of self-reported year of diagnosis among participants in a longitudinal study of people with multiple sclerosis', Multiple Sclerosis and Related Disorders, 49 pp. 1-6. ISSN 2211-0356 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.102755 [eCite] [Details]

Co-authors: Claflin SB; Zhou Y; van der Mei I

Tweet

2021Clarke L, Arnett S, Bukhari W, Khalilidehkordi E, Sanchez S, et al., 'MRI patterns distinguish AQP4 antibody positive Neuromyelitis Optica Spectrum disorder from multiple sclerosis', Frontiers in Neurology, 12 Article 722237. ISSN 1664-2295 (2021) [Refereed Article]

DOI: 10.3389/fneur.2021.722237 [eCite] [Details]

Citations: Scopus - 4Web of Science - 3

Co-authors: Stankovich J

Tweet

2021Daly A, Martin C, Sherriff J, Mori TA, Pereira G, et al., 'Omega-3 Index, fish consumption, use of fish oil supplements and first clinical diagnosis of central nervous system demyelination', Multiple Sclerosis and Related Disorders, 55 pp. 1-4. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103210 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: van der Mei I

Tweet

2021Fuh-Ngwa V, Zhou Y, Charlesworth J, Ponsonby A-L, Simpson-Yap S, et al., 'Developing a clinical-environmental-genotypic prognostic index for relapsing-onset multiple sclerosis and clinically isolated syndrome', Brain Communications, 3, (4) pp. 1-16. ISSN 2632-1297 (2021) [Refereed Article]

DOI: 10.1093/braincomms/fcab288 [eCite] [Details]

Citations: Scopus - 2Web of Science - 4

Co-authors: Zhou Y; Charlesworth J; Simpson-Yap S

Tweet

2021Krishnadas N, Taylor B, 'Incidence of idiopathic intracranial hypertension in Southern Tasmania, Australia', BMJ Neurology Open, 3, (1) pp. 1-6. ISSN 2632-6140 (2021) [Refereed Article]

DOI: 10.1136/bmjno-2021-000145 [eCite] [Details]

Tweet

2021Lo LMP, Taylor BVM, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study', European Journal of Neurology, 28, (7) pp. 2269-2279. ISSN 1351-5101 (2021) [Refereed Article]

DOI: 10.1111/ene.14887 [eCite] [Details]

Citations: Scopus - 3Web of Science - 4

Co-authors: Winzenberg T; Palmer AJ; Blizzard L; Hussain MA; van der Mei I

Tweet

2021Maltby VE, Lea RA, Monif M, Fabis-Pedrini MJ, Buzzard K, et al., 'Efficacy of cladribine tablets as a treatment for people with multiple sclerosis: protocol for the CLOBAS study (cladribine, a multicenter, long-term efficacy and biomarker Australian study)', JMIR Research Protocols, 10, (10) pp. 1-12. ISSN 1929-0748 (2021) [Refereed Article]

DOI: 10.2196/24969 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Kermode AG

Tweet

2021Marck CH, Probst Y, Chen J, Taylor BVM, van der Mei I, 'Dietary patterns and associations with health outcomes in Australian people with multiple sclerosis', European Journal of Clinical Nutrition, 75, (10) pp. 1506-1514. ISSN 0954-3007 (2021) [Refereed Article]

DOI: 10.1038/s41430-021-00864-y [eCite] [Details]

Citations: Scopus - 19Web of Science - 17

Co-authors: Chen J; van der Mei I

Tweet

2021Mehta A, Lu P, Taylor BVM, Charlesworth J, Cook AL, et al., 'Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosis', Stem Cell Research, 57 pp. 1-4. ISSN 1873-5061 (2021) [Refereed Article]

DOI: 10.1016/j.scr.2021.102568 [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Co-authors: Mehta A; Charlesworth J; Cook AL; Burdon KP; Hewitt AW; Young KM

Tweet

2021Sabel CE, Pearson JF, Mason DF, Willoughby E, Abernethy DA, et al., 'The latitude gradient for multiple sclerosis prevalence is established in the early life course', Brain, 144, (7) pp. 2038-2046. ISSN 0006-8950 (2021) [Refereed Article]

DOI: 10.1093/brain/awab104 [eCite] [Details]

Citations: Scopus - 11Web of Science - 8

Tweet

2021Vandebergh M, Andlauer TFM, Zhou Y, Mallants K, Held F, et al., 'Genetic variation in WNT9B increases relapse hazard in Multiple Sclerosis', Annals of Neurology, 89, (5) pp. 884-894. ISSN 0364-5134 (2021) [Refereed Article]

DOI: 10.1002/ana.26061 [eCite] [Details]

Citations: Scopus - 5

Co-authors: Zhou Y

Tweet

2021Yang Y, Musco H, Simpson-Yap S, Zhu Z, Wang Y, et al., 'Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases', Nature Communications, 12 Article 5641. ISSN 2041-1723 (2021) [Refereed Article]

DOI: 10.1038/s41467-021-25768-0 [eCite] [Details]

Citations: Scopus - 12Web of Science - 14

Co-authors: Lin X; Zhou Y

Tweet

2021Zarghami A, Li Y, Claflin SB, van der Mei I, Taylor BVM, 'Role of environmental factors in multiple sclerosis', Expert Review of Neurotherapeutics pp. 1-20. ISSN 1473-7175 (2021) [Refereed Article]

DOI: 10.1080/14737175.2021.1978843 [eCite] [Details]

Citations: Scopus - 11Web of Science - 12

Co-authors: Zarghami A; Claflin SB; van der Mei I

Tweet

2021Zhou Y, Cuellar-Partida G, Simpson Yap S, Lin X, Claflin S, et al., 'Utilising multi-large omics data to elucidate biological mechanisms within multiple sclerosis genetic susceptibility loci', Multiple Sclerosis Journal Article online ahead of print. ISSN 1352-4585 (2021) [Refereed Article]

DOI: 10.1177/13524585211004422 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Zhou Y; Simpson Yap S; Lin X; Claflin S; Burdon K; Charlesworth J

Tweet

2020Ahmad H, Campbell JA, van der Mei I, Taylor BV, Zhao T, et al., 'The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: results from updated and detailed data on types of costs', Multiple Sclerosis and Related Disorders, 44 Article 102247. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2020.102247 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Ahmad H; Campbell JA; van der Mei I; Zhao T; Palmer AJ

Tweet

2020Ahmad H, van der Mei I, Taylor BV, Campbell JA, Palmer AJ, 'Measuring the health-related quality of life in Australians with Multiple Sclerosis using the Assessment of Quality of Life-8-Dimension (AQoL-8D) multi-attribute utility instrument', Multiple Sclerosis and Related Disorders, 44 pp. 1-10. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2020.102358 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Ahmad H; van der Mei I; Campbell JA; Palmer AJ

Tweet

2020Auderset LF, Pitman KA, Cullen CL, Pepper RE, Taylor BV, et al., 'Low-density lipoprotein receptor-related protein 1 (LRP1) is a negative regulator of oligodendrocyte progenitor cell differentiation in the adult mouse brain', Frontiers in Cell and Developmental Biology, 8 Article 564351. ISSN 2296-634X (2020) [Refereed Article]

DOI: 10.3389/fcell.2020.564351 [eCite] [Details]

Citations: Scopus - 15Web of Science - 16

Co-authors: Auderset LF; Pitman KA; Cullen CL; Pepper RE; Foa L; Young KM

Tweet

2020Bessing B, Honan CA, van der Mei I, Taylor BV, Claflin SB, 'Development and psychometric properties of the Multiple Sclerosis Knowledge Assessment Scale: Rasch analysis of a novel tool for evaluating MS knowledge', Multiple Sclerosis Journal pp. 1-11. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458520929626 [eCite] [Details]

Citations: Scopus - 8Web of Science - 6

Co-authors: Bessing B; Honan CA; van der Mei I; Claflin SB

Tweet

2020Bostock ECS, Kirkby KC, Taylor BV, Hawrelak JA, 'Consumer reports of 'Keto Flu' associated with the ketogenic diet', Frontiers in Nutrition, 7 Article 20. ISSN 2296-861X (2020) [Refereed Article]

DOI: 10.3389/fnut.2020.00020 [eCite] [Details]

Citations: Scopus - 35Web of Science - 34

Co-authors: Bostock ECS; Kirkby KC; Hawrelak JA

Tweet

2020Bostock ECS, Kirkby KC, Taylor BV, Hawrelak JA, 'Response: Commentary: Consumer reports of 'Keto Flu' associated with the ketogenic diet', Frontiers in Nutrition ISSN 2296-861X (2020) [Contribution to Refereed Journal]

DOI: 10.3389/fnut.2020.575713 [eCite] [Details]

Citations: Scopus - 4

Co-authors: Bostock ECS; Kirkby KC; Hawrelak JA

Tweet

2020Campbell JA, Simpson Jr S, Ahmad H, Taylor BV, van der Mei I, et al., 'Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease modifying therapy prescription data', Multiple Sclerosis Journal, 26, (11) pp. 1315-1328. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458519861270 [eCite] [Details]

Citations: Scopus - 27Web of Science - 28

Co-authors: Campbell JA; Simpson Jr S; Ahmad H; van der Mei I; Palmer AJ

Tweet

2020Chen J, Taylor B, Blizzard L, Simpson-Yap S, Palmer AJ, et al., 'Risk factors for leaving employment due to multiple sclerosis and changes in risk over the past decades: using competing risk survival analysis', Multiple Sclerosis Journal pp. 1-12. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458520954167 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Chen J; Blizzard L; Simpson-Yap S; Palmer AJ; van der Mei I

Tweet

2020Claflin SB, Gates R, Maher M, Taylor BV, 'Building a successful massive open online course about multiple sclerosis: a process description', Journal of Medical Internet Research, 22, (7) Article e16687. ISSN 1439-4456 (2020) [Refereed Article]

DOI: 10.2196/16687 [eCite] [Details]

Citations: Scopus - 14Web of Science - 11

Co-authors: Claflin SB; Gates R

Tweet

2020Gresle MM, Jordan MA, Stankovich J, Spelman T, Johnson LJ, et al., 'Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells', Life Science Alliance, 3, (7) Article e202000650. ISSN 2575-1077 (2020) [Refereed Article]

DOI: 10.26508/lsa.202000650 [eCite] [Details]

Citations: Scopus - 15Web of Science - 14

Co-authors: Charlesworth J

Tweet

2020Hughes AM, Ponsonby A-L, Dear K, Dwyer T, Taylor BV, et al., 'Childhood infections, vaccinations, and tonsillectomy and risk of first clinical diagnosis of CNS demyelination in the Ausimmune Study', Multiple Sclerosis and Related Disorders, 42 Article 102062. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2020.102062 [eCite] [Details]

Citations: Scopus - 3Web of Science - 4

Co-authors: van der Mei I

Tweet

2020Hussain S, Singh A, Baxi H, Taylor B, Burgess J, et al., 'Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence', Neurological Sciences pp. 1-7. ISSN 1590-1874 (2020) [Refereed Article]

DOI: 10.1007/s10072-020-04494-3 [eCite] [Details]

Citations: Scopus - 13Web of Science - 13

Co-authors: Singh A; Burgess J; Antony B

Tweet

2020Khalilidehkordi E, Clarke L, Arnett S, Bukhari W, Jimenez Sanchez S, et al., 'Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation', Frontiers in Neurology, 11 Article 537. ISSN 1664-2295 (2020) [Refereed Article]

DOI: 10.3389/fneur.2020.00537 [eCite] [Details]

Citations: Scopus - 20Web of Science - 18

Co-authors: Stankovich J

Tweet

2020Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms', Journal of Neurology, (September) pp. 1-10. ISSN 0340-5354 (2020) [Refereed Article]

DOI: 10.1007/s00415-020-10192-z [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Co-authors: Winzenberg T; Palmer AJ; Blizzard L; van der Mei I

Tweet

2020Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis', Journal of Neurology, (September) pp. 1-13. ISSN 0340-5354 (2020) [Refereed Article]

DOI: 10.1007/s00415-020-10195-w [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Winzenberg T; Palmer AJ; Blizzard L; Ahmad H; Hussain MA; van der Mei I

Tweet

2020Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis', Journal of Neurology, (September) pp. 1-11. ISSN 0340-5354 (2020) [Refereed Article]

DOI: 10.1007/s00415-020-10194-x [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Winzenberg T; Palmer AJ; Blizzard L; van der Mei I

Tweet

2020Marx W, Hockey M, McGuinness AJ, Lane M, Christodoulou J, et al., 'The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: a systematic review', Multiple Sclerosis and Related Disorders, 37 Article 101486. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2019.101486 [eCite] [Details]

Citations: Scopus - 7Web of Science - 5

Co-authors: van der Mei I

Tweet

2020Simpson-Yap S, Oddy WH, Taylor B, Lucas RM, Black LJ, et al., 'High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis', Multiple Sclerosis Journal pp. 1-13. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458520943087 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Co-authors: Simpson-Yap S; Oddy WH; Blizzard L; van der Mei I

Tweet

2020Tracy JA, Taylor BV, Kiernan M, Dyck PJ, Crum BA, et al., 'Nerve pathology distinguishes focal motor chronic inflammatory demyelinating polyradiculoneuropathy from multifocal motor neuropathy', Journal of Clinical Neuromuscular Disease, 22, (1) pp. 1-10. ISSN 1522-0443 (2020) [Refereed Article]

DOI: 10.1097/CND.0000000000000279 [eCite] [Details]

Citations: Scopus - 3

Tweet

2020Yeh WZ, Dyck PJ, van den Berg LH, Kiernan MC, Taylor BV, 'Multifocal motor neuropathy: controversies and priorities', Journal of Neurology, Neurosurgery and Psychiatry, 91, (2) pp. 140-148. ISSN 0022-3050 (2020) [Refereed Article]

DOI: 10.1136/jnnp-2019-321532 [eCite] [Details]

Citations: Scopus - 28Web of Science - 24

Tweet

2020Zhang Y, Taylor BV, Simpson Jr S, Blizzard L, Campbell JA, et al., 'Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype', Multiple Sclerosis Journal, (September) pp. 1-14. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458520958369 [eCite] [Details]

Citations: Scopus - 19Web of Science - 17

Co-authors: Simpson Jr S; Blizzard L; Campbell JA; Palmer AJ; van der Mei I

Tweet

2020Zhang Y, Taylor BV, Simpson Jr S, Blizzard L, Palmer AJ, et al., 'Validation of 0-10 MS symptom scores in the Australian multiple sclerosis longitudinal study', Multiple Sclerosis and Related Disorders, 39 Article 101895. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2019.101895 [eCite] [Details]

Citations: Scopus - 15Web of Science - 15

Co-authors: Simpson Jr S; Blizzard L; Palmer AJ; van der Mei I

Tweet

2019Afrasiabi A, Parnell GP, Fewings N, Schibeci SD, Basuki MA, et al., 'Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility', Genome Medicine, 11, (1) Article 26. ISSN 1756-994X (2019) [Refereed Article]

DOI: 10.1186/s13073-019-0640-z [eCite] [Details]

Citations: Scopus - 28Web of Science - 24

Co-authors: Zhou Y

Tweet

2019Chen J, Taylor B, Winzenberg T, Palmer AJ, Kirk-Brown A, et al., 'Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis', Multiple Sclerosis Journal, (June) pp. 1-10. ISSN 1352-4585 (2019) [Refereed Article]

DOI: 10.1177/1352458519872644 [eCite] [Details]

Citations: Scopus - 15Web of Science - 16

Co-authors: Chen J; Winzenberg T; Palmer AJ; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2019Claflin SB, Broadley S, Taylor BV, 'The effect of disease modifying therapies on disability progression in multiple sclerosis: a systematic overview of meta-analyses', Frontiers in Neurology, 9 Article 1150. ISSN 1664-2295 (2019) [Refereed Article]

DOI: 10.3389/fneur.2018.01150 [eCite] [Details]

Citations: Scopus - 24Web of Science - 28

Co-authors: Claflin SB

Tweet

2019Claflin SB, Tan B, Taylor BV, 'The long-term effects of disease modifying therapies on disability in people living with multiple sclerosis: a systematic review and meta-analysis', Multiple Sclerosis and Related Disorders, 36 Article 101374. ISSN 2211-0348 (2019) [Refereed Article]

DOI: 10.1016/j.msard.2019.08.016 [eCite] [Details]

Citations: Scopus - 5Web of Science - 6

Co-authors: Claflin SB; Tan B

Tweet

2019Lu M, McComish BJ, Burdon KP, Taylor BV, Korner H, 'The association between vitamin D and multiple sclerosis risk: 1,25(OH)2D3 induces super-enhancers bound by VDR', Frontiers in Immunology, 10 Article 488. ISSN 1664-3224 (2019) [Refereed Article]

DOI: 10.3389/fimmu.2019.00488 [eCite] [Details]

Citations: Scopus - 17Web of Science - 17

Co-authors: McComish BJ; Burdon KP; Korner H

Tweet

2019Madireddy L, Patsopoulos NA, Cotsapas C, Bos SD, Beecham A, et al., 'A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis', Nature Communications, 10 Article 2236. ISSN 2041-1723 (2019) [Refereed Article]

DOI: 10.1038/s41467-019-09773-y [eCite] [Details]

Citations: Scopus - 48Web of Science - 48

Tweet

2019Palmer AJ, van der Mei I, Taylor BV, Clarke PM, Simpson Jr S, et al., 'Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: evidence from Australia', Multiple Sclerosis Journal pp. 1-10. ISSN 1352-4585 (2019) [Refereed Article]

DOI: 10.1177/1352458519831213 [eCite] [Details]

Citations: Scopus - 13Web of Science - 12

Co-authors: Palmer AJ; van der Mei I; Simpson Jr S; Ahmad H

Tweet

2019Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Taylor B, et al., 'Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility', Science, 365, (6460) pp. 1-13. ISSN 0036-8075 (2019) [Refereed Article]

DOI: 10.1126/science.aav7188 [eCite] [Details]

Citations: Scopus - 471Web of Science - 434

Co-authors: Charlesworth JC; Molyneux PD

Tweet

2019Simpson Jr S, Wang W, Otahal P, Blizzard L, van der Mei IAF, et al., 'Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis', Journal of Neurology, Neurosurgery and Psychiatry, 90, (11) pp. 1193-1200. ISSN 0022-3050 (2019) [Refereed Article]

DOI: 10.1136/jnnp-2018-320189 [eCite] [Details]

Citations: Scopus - 50Web of Science - 51

Co-authors: Simpson Jr S; Otahal P; Blizzard L; van der Mei IAF

Tweet

2019Suanprasert N, Taylor BV, Klein CJ, Roforth MM, Karam C, et al., 'Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis', Multiple Sclerosis and Related Disorders, 30 pp. 284-290. ISSN 2211-0348 (2019) [Refereed Article]

DOI: 10.1016/j.msard.2019.02.026 [eCite] [Details]

Citations: Scopus - 5Web of Science - 7

Tweet

2019Zhang Y, Zhou Y, van der Mei IAF, Simpson S, Ponsonby A-L, et al., 'Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry pp. 1-6. ISSN 0022-3050 (2019) [Refereed Article]

DOI: 10.1136/jnnp-2018-319870 [eCite] [Details]

Citations: Scopus - 13Web of Science - 12

Co-authors: Zhang Y; Zhou Y; van der Mei IAF; Simpson S; Tettey P; Charlesworth J

Tweet

2019Zhou Y, Claflin SB, Stankovich J, van der Mei I, Simpson Jr S, et al., 'Redefining the Multiple Sclerosis Severity Score (MSSS): the effect of sex and onset phenotype', Multiple Sclerosis Journal, (October) pp. 1-10. ISSN 1352-4585 (2019) [Refereed Article]

DOI: 10.1177/1352458519881994 [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Zhou Y; Claflin SB; van der Mei I; Simpson Jr S; Blizzard L

Tweet

2018Ahmad H, van der Mei I, Taylor BV, Lucas RM, Ponsonby A-L, et al., 'Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis', Multiple Sclerosis Journal pp. 1-9. ISSN 1352-4585 (2018) [Refereed Article]

DOI: 10.1177/1352458518806103 [eCite] [Details]

Citations: Scopus - 8Web of Science - 6

Co-authors: Ahmad H; van der Mei I; Simpson S; Palmer AJ

Tweet

2018Bostock EC, Kirkby K, Garry M, Taylor B, Hawrelak JA, 'Mania associated with herbal medicines, other than Cannabis: a systematic review and quality assessment of case reports', Frontiers in Psychiatry, 9 Article 280. ISSN 1664-0640 (2018) [Refereed Article]

DOI: 10.3389/fpsyt.2018.00280 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Bostock EC; Kirkby K; Garry M; Hawrelak JA

Tweet

2018Chen J, Taylor B, Palmer AJ, Kirk-Brown A, van Dijk P, et al., 'Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis', Multiple Sclerosis Journal, (June) pp. 1-11. ISSN 1352-4585 (2018) [Refereed Article]

DOI: 10.1177/1352458518781971 [eCite] [Details]

Citations: Scopus - 37Web of Science - 33

Co-authors: Chen J; Palmer AJ; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2018Chen J, Taylor BV, Blizzard L, Simpson Jr S, Palmer AJ, et al., 'Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data', Journal of Neurology, Neurosurgery and Psychiatry, 89, (11) pp. 1200-1207. ISSN 0022-3050 (2018) [Refereed Article]

DOI: 10.1136/jnnp-2018-318228 [eCite] [Details]

Citations: Scopus - 35Web of Science - 32

Co-authors: Chen J; Blizzard L; Simpson Jr S; Palmer AJ; van der Mei IAF

Tweet

2018Graves JS, Barcellos LF, Simpson S, Belman A, Lin R, et al., 'The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults', Multiple Sclerosis and Related Disorders, 19 pp. 161-165. ISSN 2211-0348 (2018) [Refereed Article]

DOI: 10.1016/j.msard.2017.10.008 [eCite] [Details]

Citations: Scopus - 10Web of Science - 9

Co-authors: Simpson S; Ponsonby A-L; Dwyer T; van der Mei IAF

Tweet

2018Jia X, Madireddy L, Caillier S, Santaniello A, Esposito F, et al., 'Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis', Annals of Neurology, 84, (1) pp. 51-63. ISSN 0364-5134 (2018) [Refereed Article]

DOI: 10.1002/ana.25263 [eCite] [Details]

Citations: Scopus - 30Web of Science - 27

Co-authors: Zhou Y

Tweet

2018Jokubaitis VG, Zhou Y, Butzkueven H, Taylor BV, 'Genotype and phenotype in Multiple Sclerosis - potential for disease course prediction?', Current Treatment Options in Neurology, 20, (6) Article 18. ISSN 1092-8480 (2018) [Refereed Article]

DOI: 10.1007/s11940-018-0505-6 [eCite] [Details]

Citations: Scopus - 6Web of Science - 7

Co-authors: Zhou Y

Tweet

2018Lu M, Taylor BV, Korner H, 'Genomic effects of the vitamin D receptor: Potentially the link between vitamin D, immune cells, and multiple sclerosis', Frontiers in Immunology, 9 Article 477. ISSN 1664-3224 (2018) [Refereed Article]

DOI: 10.3389/fimmu.2018.00477 [eCite] [Details]

Citations: Scopus - 39Web of Science - 37

Co-authors: Lu M; Korner H

Tweet

2018Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, et al., 'Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM', Muscle and Nerve, 57, (6) pp. 1000-1005. ISSN 0148-639X (2018) [Refereed Article]

DOI: 10.1002/mus.26051 [eCite] [Details]

Citations: Scopus - 9Web of Science - 10

Tweet

2018McLaughlin L, Clarke L, Khalilidehkordi E, Butzkueven H, Taylor B, et al., 'Vitamin D for the treatment of multiple sclerosis: a meta-analysis', Journal of Neurology, 265, (12) pp. 2893-2905. ISSN 0340-5354 (2018) [Refereed Article]

DOI: 10.1007/s00415-018-9074-6 [eCite] [Details]

Citations: Scopus - 59Web of Science - 61

Tweet

2018Mitrovic M, Patsopoulos NA, Beecham AH, Dankowski T, Goris A, et al., 'Low-frequency and rare-coding variation contributes to multiple sclerosis risk', Cell, 175, (6) pp. 1679-1687. ISSN 0092-8674 (2018) [Refereed Article]

DOI: 10.1016/j.cell.2018.09.049 [eCite] [Details]

Citations: Scopus - 81Web of Science - 72

Co-authors: Charlesworth J

Tweet

2018Saul A, Taylor B, Simpson Jr S, Ponsonby A-L, Blizzard L, et al., 'Polymorphism in the serotonin transporter gene polymorphisms (5-HTTLPR) modifies the association between significant life events and depression in people with multiple sclerosis', Multiple Sclerosis Journal pp. 1-8. ISSN 1352-4585 (2018) [Refereed Article]

DOI: 10.1177/1352458518770021 [eCite] [Details]

Citations: Scopus - 4Web of Science - 3

Co-authors: Saul A; Simpson Jr S; Blizzard L; Wood B; van der Mei IAF

Tweet

2018Signori A, Izquierdo G, Lugaresi A, Hupperts R, Grand'Maison F, et al., 'Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis', Multiple Sclerosis Journal, 24, (5) pp. 642-652. ISSN 1352-4585 (2018) [Refereed Article]

DOI: 10.1177/1352458517703800 [eCite] [Details]

Citations: Scopus - 24Web of Science - 24

Tweet

2018Simpson Jr S, Van Der Mei I, Lucas RM, Ponsonby A-L, Broadley S, et al., 'Sun exposure across the life course significantly modulates early multiple sclerosis clinical course', Frontiers in Neurology, 9, (FEB) Article 16. ISSN 1664-2295 (2018) [Refereed Article]

DOI: 10.3389/fneur.2018.00016 [eCite] [Details]

Citations: Scopus - 25Web of Science - 24

Co-authors: Simpson Jr S; Van Der Mei I; Blizzard L

Tweet

2018Simpson Jr S, van der Mei I, Taylor B, 'The role of vitamin D in multiple sclerosis: biology & biochemistry, epidemiology and potential roles in treatment', Medicinal Chemistry, 14, (2) pp. 129-143. ISSN 1573-4064 (2018) [Refereed Article]

DOI: 10.2174/1573406413666170921143600 [eCite] [Details]

Citations: Scopus - 16Web of Science - 16

Co-authors: Simpson Jr S; van der Mei I

Tweet

2018Tao C, Simpson Jr S, Taylor BV, Blizzard L, Lucas RM, et al., 'Onset symptoms, tobacco smoking, and progressive-onset phenotype are associated with a delayed onset of multiple sclerosis, and marijuana use with an earlier onset', Frontiers in Neurology, 9, (JUN) Article 418. ISSN 1664-2295 (2018) [Refereed Article]

DOI: 10.3389/fneur.2018.00418 [eCite] [Details]

Citations: Scopus - 7Web of Science - 6

Co-authors: Simpson Jr S; Blizzard L; van der Mei I

Tweet

2018Yeh WZ, Blizzard L, Taylor BV, 'What is the actual prevalence of migraine?', Brain and Behavior, 8, (6) Article e00950. ISSN 2162-3279 (2018) [Refereed Article]

DOI: 10.1002/brb3.950 [eCite] [Details]

Citations: Scopus - 77Web of Science - 69

Co-authors: Blizzard L

Tweet

2018Zhang Y, Taylor BV, Simpson Jr S, Blizzard L, van der Mei I, 'Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process', European Journal of Neurology, 26, (1) pp. 155-161. ISSN 1351-5101 (2018) [Refereed Article]

DOI: 10.1111/ene.13786 [eCite] [Details]

Citations: Scopus - 14Web of Science - 13

Co-authors: Zhang Y; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2018Zhou Y, Chen M, Simpson Jr S, Lucas RM, Charlesworth JC, et al., 'Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis', Neurological Sciences, 39, (2) pp. 297-304. ISSN 1590-1874 (2018) [Refereed Article]

DOI: 10.1007/s10072-017-3177-1 [eCite] [Details]

Citations: Scopus - 16Web of Science - 16

Co-authors: Zhou Y; Simpson Jr S; Charlesworth JC; Blackburn N; van der Mei I

Tweet

2017Ahmad H, Taylor BV, van der Mei I, Colman S, O'Leary BA, et al., 'The impact of multiple sclerosis severity on health state utility values: Evidence from Australia', Multiple Sclerosis Journal, 23, (8) pp. 1157-1166. ISSN 1352-4585 (2017) [Refereed Article]

DOI: 10.1177/1352458516672014 [eCite] [Details]

Citations: Scopus - 23Web of Science - 24

Co-authors: Ahmad H; van der Mei I; Breslin M; Palmer AJ

Tweet

2017Bostock EC, Kirkby KC, Garry MI, Taylor BVM, 'Systematic Review of Cognitive Function in Euthymic Bipolar Disorder and Pre-Surgical Temporal Lobe Epilepsy', Frontiers in Psychiatry, 8 Article 133. ISSN 1664-0640 (2017) [Refereed Article]

DOI: 10.3389/fpsyt.2017.00133 [eCite] [Details]

Citations: Scopus - 13Web of Science - 8

Co-authors: Bostock EC; Kirkby KC; Garry MI

Tweet

2017Bostock EC, Kirkby KC, Taylor BVM, 'The current status of the ketogenic diet in psychiatry', Frontiers in Psychiatry, 8 Article 43. ISSN 1664-0640 (2017) [Refereed Article]

DOI: 10.3389/fpsyt.2017.00043 [eCite] [Details]

Citations: Scopus - 65Web of Science - 55

Co-authors: Bostock EC; Kirkby KC

Tweet

2017Bukhari W, Prain KM, Waters P, Woodhall M, O'Gorman CM, et al., 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology, Neurosurgery and Psychiatry, 88 pp. 632-638. ISSN 0022-3050 (2017) [Refereed Article]

DOI: 10.1136/jnnp-2016-314839 [eCite] [Details]

Citations: Scopus - 77Web of Science - 72

Co-authors: Stankovich J

Tweet

2017Claflin SB, van der Mei IAF, Taylor BV, 'Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016', Journal of Neurology, Neurosurgery and Psychiatry, 8, (1) pp. 34-41. ISSN 0022-3050 (2017) [Refereed Article]

DOI: 10.1136/jnnp-2016-314490 [eCite] [Details]

Citations: Scopus - 27Web of Science - 23

Co-authors: Claflin SB; van der Mei IAF

Tweet

2017Lim CK, Bilgin A, Lovejoy DB, Tan V, Bustamante S, et al., 'Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression', Scientific Reports, 7 Article 41473. ISSN 2045-2322 (2017) [Refereed Article]

DOI: 10.1038/srep41473 [eCite] [Details]

Citations: Scopus - 148Web of Science - 149

Tweet

2017Mahurkar S, Moldovan M, Suppiah V, Sorosina M, Clarelli F, et al., 'Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study', Pharmacogenomics Journal, 17 pp. 312-318. ISSN 1470-269X (2017) [Refereed Article]

DOI: 10.1038/tpj.2016.20 [eCite] [Details]

Citations: Scopus - 22Web of Science - 20

Tweet

2017Manousaki D, Dudding T, Haworth S, Hsu Y-H, Liu C-T, et al., 'Low-frequency synonymous coding variation in CYP2R1 has large effects on Vitamin D levels and risk of multiple sclerosis', American Journal of Human Genetics, 101, (2) pp. 227-238. ISSN 0002-9297 (2017) [Refereed Article]

DOI: 10.1016/j.ajhg.2017.06.014 [eCite] [Details]

Citations: Scopus - 83Web of Science - 79

Tweet

2017Odenthal C, Simpson Jr S, Oughton J, van der Mei I, Rose S, et al., 'Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study', Journal of Medical Imaging and Radiation Oncology, 61, (4) pp. 453-460. ISSN 1754-9477 (2017) [Refereed Article]

DOI: 10.1111/1754-9485.12570 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Simpson Jr S; van der Mei I

Tweet

2017Pearson JF, Alla S, Clarke G, Mason DF, Anderson T, et al., 'Multiple Sclerosis impact on employment and income in New Zealand', Acta Neurologica Scandinavica, 136, (3) pp. 223-232. ISSN 0001-6314 (2017) [Refereed Article]

DOI: 10.1111/ane.12714 [eCite] [Details]

Citations: Scopus - 21Web of Science - 21

Tweet

2017Premilovac D, Gasperini RJ, Sawyer S, West A, Keske M, et al., 'A New Method for Targeted and Sustained Induction of Type 2 Diabetes in Rodents', Scientific Reports, 7 Article 14158. ISSN 2045-2322 (2017) [Refereed Article]

DOI: 10.1038/s41598-017-14114-4 [eCite] [Details]

Citations: Scopus - 18Web of Science - 17

Co-authors: Premilovac D; Gasperini RJ; Sawyer S; West A; Keske M; Foa L

Tweet

2017Saul A, Ponsonby A-L, Lucas RM, Taylor BV, Simpson Jr S, et al., 'Stressful life events and the risk of initial central nervous system demyelination', Multiple Sclerosis Journal, 23, (7) pp. 1000-1007. ISSN 1352-4585 (2017) [Refereed Article]

DOI: 10.1177/1352458516667566 [eCite] [Details]

Citations: Scopus - 3Web of Science - 9

Co-authors: Saul A; Simpson Jr S; van der Mei IAF

Tweet

2017Stewart T, Spelman T, Havrdova E, Horakova D, Trojano M, et al., 'Contribution of different relapse phenotypes to disability in multiple sclerosis', Multiple Sclerosis Journal, 23, (2) pp. 266-276. ISSN 1352-4585 (2017) [Refereed Article]

DOI: 10.1177/1352458516643392 [eCite] [Details]

Citations: Scopus - 29Web of Science - 24

Tweet

2017Tao C, Simpson Jr S, Taylor BV, van der Mei I, 'Association between human herpesvirus & human endogenous retrovirus and MS onset & progression', Journal of the Neurological Sciences, 372 pp. 239-249. ISSN 0022-510X (2017) [Refereed Article]

DOI: 10.1016/j.jns.2016.11.060 [eCite] [Details]

Citations: Scopus - 16Web of Science - 16

Co-authors: Simpson Jr S; van der Mei I

Tweet

2017Tettey P, Simpson S, Taylor B, Ponsonby A-L, Lucas RM, et al., 'An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event', Journal of Neurology, Neurosurgery and Psychiatry, 88, (5) pp. 395-401. ISSN 0022-3050 (2017) [Refereed Article]

DOI: 10.1136/jnnp-2016-315037 [eCite] [Details]

Citations: Scopus - 57Web of Science - 56

Co-authors: Tettey P; Simpson S; van der Mei IAF

Tweet

2017Van Dijk PA, Kirk-Brown AK, Taylor B, van der Mei I, 'Closing the gap: Longitudinal changes in employment for Australians with multiple sclerosis', Multiple Sclerosis Journal, 23, (10) pp. 1415-1423. ISSN 1352-4585 (2017) [Refereed Article]

DOI: 10.1177/1352458516678934 [eCite] [Details]

Citations: Scopus - 14Web of Science - 12

Co-authors: van der Mei I

Tweet

2017Zhou Y, Graves JS, Simpson S, Charlesworth JC, van der Mei I, et al., 'Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 88, (10) pp. 864-868. ISSN 0022-3050 (2017) [Refereed Article]

DOI: 10.1136/jnnp-2017-315971 [eCite] [Details]

Citations: Scopus - 15Web of Science - 13

Co-authors: Zhou Y; Simpson S; Charlesworth JC; van der Mei I

Tweet

2017Zhou Y, Simpson Jr S, Charlesworth JC, van der Mei I, Lucas RM, et al., 'Variation within MBP gene predicts disease course in multiple sclerosis', Brain and Behavior, 7, (4) Article e00670. ISSN 2162-3279 (2017) [Refereed Article]

DOI: 10.1002/brb3.670 [eCite] [Details]

Citations: Scopus - 13Web of Science - 12

Co-authors: Zhou Y; Simpson Jr S; Charlesworth JC; van der Mei I

Tweet

2016Alla S, Pearson JF, Taylor BV, Miller DH, Clarke G, et al., 'Disability profile of multiple sclerosis in New Zealand', Journal of Clinical Neuroscience, 28 pp. 97-101. ISSN 0967-5868 (2016) [Refereed Article]

DOI: 10.1016/j.jocn.2015.09.020 [eCite] [Details]

Citations: Scopus - 4Web of Science - 3

Tweet

2016George MF, Briggs FBS, Shao X, Gianfrancesco MA, Kockum I, et al., 'Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies', Neurology: Genetics, 2, (4) Article e87. ISSN 2376-7839 (2016) [Refereed Article]

DOI: 10.1212/NXG.0000000000000087 [eCite] [Details]

Citations: Scopus - 61

Co-authors: van der Mei I; Zhou Y

Tweet

2016Landowski LM, Dyck PJB, Engelstad J, Taylor BV, 'Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration', Journal of Chemical Neuroanatomy, 76, (Pt A) pp. 19-27. ISSN 0891-0618 (2016) [Refereed Article]

DOI: 10.1016/j.jchemneu.2016.04.006 [eCite] [Details]

Citations: Scopus - 28Web of Science - 26

Co-authors: Landowski LM

Tweet

2016Pan G, Simpson Jr S, van der Mei I, Charlesworth JC, Lucas R, et al., 'Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study', Journal of Neurology, Neurosurgery and Psychiatry, 87, (11) pp. 1204-1211. ISSN 0022-3050 (2016) [Refereed Article]

DOI: 10.1136/jnnp-2016-313722 [eCite] [Details]

Citations: Scopus - 28Web of Science - 25

Co-authors: Pan G; Simpson Jr S; van der Mei I; Charlesworth JC; Zhou Y; Wu F

Tweet

2016Siejka D, Taylor B, Ponsonby A-L, Dwyer T, van der Mei I, 'Association between exposure to farm animals and pets and risk of Multiple Sclerosis', Multiple Sclerosis and Related Disorders, 10 pp. 53-56. ISSN 2211-0348 (2016) [Refereed Article]

DOI: 10.1016/j.msard.2016.08.015 [eCite] [Details]

Citations: Scopus - 8Web of Science - 7

Co-authors: Siejka D; van der Mei I

Tweet

2016Simpson JR S, Stewart N, van der Mei I, Blizzard L, Taylor BV, 'Synergetic and antagonistic effects of combined calcitriol and interferon-β treatment on cytokine production by stimulated PBMCs', Journal of Neuroimmunology, 297 pp. 148-155. ISSN 0165-5728 (2016) [Refereed Article]

DOI: 10.1016/j.jneuroim.2016.05.020 [eCite] [Details]

Citations: Scopus - 2Web of Science - 4

Co-authors: Simpson JR S; Stewart N; van der Mei I; Blizzard L

Tweet

2016Simpson S, Tan H, Otahal P, Taylor B, Ponsonby AL, et al., 'Anxiety, depression and fatigue at 5-year review following CNS demyelination', Acta Neurologica Scandinavica, 134, (6) pp. 403-413. ISSN 0001-6314 (2016) [Refereed Article]

DOI: 10.1111/ane.12554 [eCite] [Details]

Citations: Scopus - 41Web of Science - 36

Co-authors: Simpson S; Tan H; Otahal P; Blizzard L; van der Mei I

Tweet

2016Tang Z, Fang Z, Huang W, Liu Z, Chen Y, et al., 'Non-Obese Diabetes and Its Associated Factors in an Underdeveloped Area of South China, Guangxi', International Journal of Environmental Research and Public Health, 13, (10) Article 976. ISSN 1660-4601 (2016) [Refereed Article]

DOI: 10.3390/ijerph13100976 [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Simpson Jr S

Tweet

2016Tao C, Simpson Jr S, van der Mei I, Blizzard L, Havrdova E, et al., 'Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 87, (12) pp. 1343-1349. ISSN 0022-3050 (2016) [Refereed Article]

DOI: 10.1136/jnnp-2016-314013 [eCite] [Details]

Citations: Scopus - 52Web of Science - 46

Co-authors: Simpson Jr S; van der Mei I; Blizzard L

Tweet

2016Tettey P, Siejka D, Simpson Jr S, Taylor B, Blizzard L, et al., 'Frequency of comorbidities and their association with clinical disability and relapse in Multiple Sclerosis', Neuroepidemiology, 46, (2) pp. 106-113. ISSN 0251-5350 (2016) [Refereed Article]

DOI: 10.1159/000442203 [eCite] [Details]

Citations: Scopus - 32Web of Science - 33

Co-authors: Tettey P; Siejka D; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2016Zhou Y, Zhu G, Charlesworth JC, Simpson Jr S, Rubicz R, et al., 'Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis', Multiple Sclerosis Journal, 22, (13) pp. 1655-1664. ISSN 1352-4585 (2016) [Refereed Article]

DOI: 10.1177/1352458515626598 [eCite] [Details]

Citations: Scopus - 30Web of Science - 25

Co-authors: Zhou Y; Charlesworth JC; Simpson Jr S; Wu F; van der Mei I

Tweet

2016van der Mei IAF, Lucas RM, Taylor BV, Valery PC, Dwyer T, et al., 'Population attributable fractions and joint effects of key risk factors for multiple sclerosis', Multiple Sclerosis Journal, 22, (4) pp. 461-469. ISSN 1352-4585 (2016) [Refereed Article]

DOI: 10.1177/1352458515594040 [eCite] [Details]

Citations: Scopus - 48Web of Science - 43

Co-authors: van der Mei IAF; Otahal P

Tweet

2015Black LJ, Anderson D, Clarke MW, Ponsonby A-L, Lucas RM, et al., 'Analytical bias in the measurement of serum 25-hydroxyvitamin D concentrations impairs assessment of vitamin D Status in clinical and research settings', PL o S One, 10, (8) Article e0135478. ISSN 1932-6203 (2015) [Refereed Article]

DOI: 10.1371/journal.pone.0135478 [eCite] [Details]

Citations: Scopus - 47Web of Science - 45

Co-authors: van der Mei I

Tweet

2015Bostock EC, Kirkby KC, Garry MI, Taylor BVM, 'Comparison of precipitating factors for mania and partial seizures: Indicative of shared pathophysiology?', Journal of Affective Disorders, 183 pp. 57-67. ISSN 0165-0327 (2015) [Refereed Article]

DOI: 10.1016/j.jad.2015.04.057 [eCite] [Details]

Citations: Scopus - 12Web of Science - 10

Co-authors: Bostock EC; Kirkby KC; Garry MI

Tweet

2015Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, 203, (3) pp. 139-141. ISSN 0025-729X (2015) [Refereed Article]

DOI: 10.5694/mja14.01218 [eCite] [Details]

Citations: Scopus - 10Web of Science - 10

Tweet

2015Dyck PJ, Taylor BV, Davies JL, Mauermann ML, Litchy WJ, et al., 'Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy', Muscle and Nerve, 52, (4) pp. 488-497. ISSN 0148-639X (2015) [Refereed Article]

DOI: 10.1002/mus.24707 [eCite] [Details]

Citations: Scopus - 16Web of Science - 15

Tweet

2015Field J, Shahijanian F, Schibeci S, Johnson L, Gresle M, et al., 'The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function', PLoS One, 10, (6) Article e0127080. ISSN 1932-6203 (2015) [Refereed Article]

DOI: 10.1371/journal.pone.0127080 [eCite] [Details]

Citations: Scopus - 27Web of Science - 23

Co-authors: Charlesworth JC

Tweet

2015Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, et al., 'Genetic variants are major determinants of CSF antibody levels in multiple sclerosis', Brain, 138, (3) pp. 632-643. ISSN 0006-8950 (2015) [Refereed Article]

DOI: 10.1093/brain/awu405 [eCite] [Details]

Citations: Scopus - 45Web of Science - 41

Tweet

2015Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, et al., 'A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis', Human Molecular Genetics, 24, (19) pp. 5644-5654. ISSN 0964-6906 (2015) [Refereed Article]

DOI: 10.1093/hmg/ddv278 [eCite] [Details]

Citations: Scopus - 44Web of Science - 42

Co-authors: Stankovich J

Tweet

2015Hoare S, Lithander F, van der Mei I, Ponsonby A-L, Lucas R, et al., 'Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study', Multiple Sclerosis, 22, (7) pp. 884-892. ISSN 1352-4585 (2015) [Refereed Article]

DOI: 10.1177/1352458515604380 [eCite] [Details]

Citations: Scopus - 59Web of Science - 56

Co-authors: van der Mei I

Tweet

2015Landowski LM, Pavez MP, Brown LS, Gasperini R, Taylor BV, et al., 'Low-density lipoprotein receptor-related proteins in a novel mechanism of axon guidance and peripheral nerve regeneration', Journal of Biological Chemistry, 291, (3) pp. 1092-1102.. ISSN 1083-351X (2015) [Refereed Article]

DOI: 10.1074/jbc.M115.668996 [eCite] [Details]

Citations: Scopus - 24Web of Science - 23

Co-authors: Landowski LM; Pavez MP; Brown LS; Gasperini R; West AK; Foa L

Tweet

2015Lin R, Taylor BV, Charlesworth J, van der Mei I, Blizzard L, et al., 'Modulating effects of WT1 on interferon-β-vitamin D association in MS', Acta Neurologica Scandinavica, 131, (4) pp. 231-239. ISSN 0001-6314 (2015) [Refereed Article]

DOI: 10.1111/ane.12315 [eCite] [Details]

Citations: Scopus - 12Web of Science - 12

Co-authors: Charlesworth J; van der Mei I; Blizzard L; Stewart N; Pittas F; Simpson JR S

Tweet

2015Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, et al., 'Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype', Journal of Neurology, Neurosurgery and Psychiatry, 86 pp. 973-985. ISSN 0022-3050 (2015) [Refereed Article]

DOI: 10.1136/jnnp-2014-309697 [eCite] [Details]

Citations: Scopus - 274Web of Science - 230

Tweet

2015Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, et al., 'Class II HLA interactions modulate genetic risk for multiple sclerosis', Nature Genetics, 47, (10) pp. 1107-1113. ISSN 1061-4036 (2015) [Refereed Article]

DOI: 10.1038/ng.3395 [eCite] [Details]

Citations: Scopus - 212Web of Science - 215

Tweet

2015Simpson JR S, Taylor BV, van der Mei I, 'The role of epidemiology in MS research: Past successes, current challenges and future potential', Multiple Sclerosis Journal, 21, (8) pp. 969-977. ISSN 1352-4585 (2015) [Refereed Article]

DOI: 10.1177/1352458515574896 [eCite] [Details]

Citations: Scopus - 30Web of Science - 24

Co-authors: Simpson JR S; van der Mei I

Tweet

2015Simpson Jr S, Mina S, Morris H, Mahendran S, Taylor B, et al., 'The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011', Acta Neurologica Scandinavica, 132, (6) pp. 381-388. ISSN 0001-6314 (2015) [Refereed Article]

DOI: 10.1111/ane.12405 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Simpson Jr S

Tweet

2015Simpson Jr S, Stewart N, van der Mei I, Otahal P, Charlesworth J, et al., 'Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: Results from a prospective cohort study', Journal of Neurology, Neurosurgery and Psychiatry, 86 pp. 200-207. ISSN 0022-3050 (2015) [Refereed Article]

DOI: 10.1136/jnnp-2013-307336 [eCite] [Details]

Citations: Scopus - 25Web of Science - 21

Co-authors: Simpson Jr S; Stewart N; van der Mei I; Otahal P; Charlesworth J; Blizzard L; Pittas F

Tweet

2015Simpson Jr S, van der Mei I, Stewart N, Blizzard L, Tettey P, et al., 'Weekly cholecalciferol supplementation results in significant reductions in infection risk among the vitamin D deficient: results from the CIPRIS pilot RCT', BMC Nutrition, 1 Article 7. ISSN 2055-0928 (2015) [Refereed Article]

DOI: 10.1186/2055-0928-1-7 [eCite] [Details]

Citations: Scopus - 16

Co-authors: Simpson Jr S; van der Mei I; Stewart N; Blizzard L; Tettey P

Tweet

2015Taylor B, Moses H, Paul F, Suarez G, Rametta M, 'Treatment of Multiple Sclerosis - Relationship between Vitamin D and Interferon β-1b', European Neurological Review, 10, (2) pp. 124-130. ISSN 1758-3837 (2015) [Refereed Article]

DOI: 10.17925/ENR.2015.10.02.124 [eCite] [Details]

Citations: Scopus - 1

Tweet

2015Tettey P, Simpson Jr S, Taylor BV, van der Mei IAF, 'The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology', Journal of the Neurological Sciences, 348, (1-2) pp. 126-131. ISSN 0022-510X (2015) [Refereed Article]

DOI: 10.1016/j.jns.2014.11.019 [eCite] [Details]

Citations: Scopus - 28Web of Science - 29

Co-authors: Tettey P; Simpson Jr S; van der Mei IAF

Tweet

2015Zhou Y, Taylor B, van der Mei I, Stewart N, Charlesworth J, et al., 'Genetic variation in PBMC-produced IFN-γ and TNF-α associations with relapse in multiple sclerosis', Journal of The Neurological Sciences, 349, (1-2) pp. 40-44. ISSN 0022-510X (2015) [Refereed Article]

DOI: 10.1016/j.jns.2014.12.022 [eCite] [Details]

Citations: Scopus - 3Web of Science - 4

Co-authors: Zhou Y; van der Mei I; Stewart N; Charlesworth J; Blizzard L; Pittas F; Simpson Jr S

Tweet

2014Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, 21, (11) pp. 1835-1846. ISSN 0967-5868 (2014) [Refereed Article]

DOI: 10.1016/j.jocn.2014.01.016 [eCite] [Details]

Citations: Scopus - 16Web of Science - 12

Tweet

2014Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy', Journal of Clinical Neuroscience, 21, (11) pp. 1847-1856. ISSN 0967-5868 (2014) [Refereed Article]

DOI: 10.1016/j.jocn.2014.01.018 [eCite] [Details]

Citations: Scopus - 18Web of Science - 14

Tweet

2014Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, et al., 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations', Journal of Clinical Neuroscience, 21, (11) pp. 1857-1865. ISSN 0967-5868 (2014) [Refereed Article]

DOI: 10.1016/j.jocn.2014.01.017 [eCite] [Details]

Citations: Scopus - 14Web of Science - 12

Tweet

2014Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, et al., 'Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity', Neurology, 83, (11) pp. 1022-1024. ISSN 0028-3878 (2014) [Contribution to Refereed Journal]

DOI: 10.1212/WNL.0000000000000768 [eCite] [Details]

Citations: Scopus - 737Web of Science - 697

Tweet

2014Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, et al., 'No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis', Human Molecular Genetics, 23, (7) pp. 1916-1922. ISSN 0964-6906 (2014) [Refereed Article]

DOI: 10.1093/hmg/ddt574 [eCite] [Details]

Citations: Scopus - 16Web of Science - 18

Co-authors: Foote SJ; Stankovich J

Tweet

2014Gresle MM, Liu Y, Dagley LF, Haartsen J, Pearson F, et al., 'Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients', Journal of Neurology, Neurosurgery and Psychiatry, 85, (11) pp. 1209-1213. ISSN 0022-3050 (2014) [Refereed Article]

DOI: 10.1136/jnnp-2013-306789 [eCite] [Details]

Citations: Scopus - 32Web of Science - 28

Tweet

2014Knippenberg S, Damoiseaux J, Bol Y, Hupperts R, Taylor BV, et al., 'Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis', Acta Neurologica Scandinavica, 129, (2) pp. 123-131. ISSN 0001-6314 (2014) [Refereed Article]

DOI: 10.1111/ane.12155 [eCite] [Details]

Citations: Scopus - 46Web of Science - 43

Co-authors: Simpson S; van der Mei IAF

Tweet

2014Lin R, Taylor BV, Simpson Jr S, Charlesworth J, Ponsonby A-L, et al., 'Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study', Multiple Sclerosis, 20, (3) pp. 313-321. ISSN 1352-4585 (2014) [Refereed Article]

DOI: 10.1177/1352458513496882 [eCite] [Details]

Citations: Scopus - 20Web of Science - 21

Co-authors: Simpson Jr S; Charlesworth J; Pittas F; van der Mei I

Tweet

2014Lin R, Taylor BV, Simpson Jr S, Charlesworth J, Ponsonby A-L, et al., 'Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 85, (4) pp. 399-404. ISSN 0022-3050 (2014) [Refereed Article]

DOI: 10.1136/jnnp-2013-305245 [eCite] [Details]

Citations: Scopus - 26Web of Science - 27

Co-authors: Simpson Jr S; Charlesworth J; Pittas F; van der Mei IAF

Tweet

2014Pearson JF, Alla S, Clarke G, Taylor BV, Miller DH, et al., 'Multiple sclerosis in New Zealand Māori', Multiple Sclerosis Journal, 20, (14) pp. 1892-1895. ISSN 1477-0970 (2014) [Refereed Article]

DOI: 10.1177/1352458514535130 [eCite] [Details]

Citations: Scopus - 11Web of Science - 11

Tweet

2014Shahijanian F, Parnell GP, McKay FC, Gatt PN, Shojoei M, et al., 'The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells', Human Molecular Genetics, 23, (6) pp. 1425-1434. ISSN 1460-2083 (2014) [Refereed Article]

DOI: 10.1093/hmg/ddt529 [eCite] [Details]

Citations: Scopus - 33Web of Science - 35

Co-authors: Charlesworth J

Tweet

2014Simpson JR S, Taylor BV, 'The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'', Multiple Sclerosis Journal, 20, (13) pp. 1675-1677. ISSN 1352-4585 (2014) [Contribution to Refereed Journal]

DOI: 10.1177/1352458514535474 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Simpson JR S

Tweet

2014Simpson Jr S, Taylor B, Burrows J, Burrows S, Dwyer DE, et al., 'EBV & HHV6 reactivation is infrequent and not associated with MS clinical course', Acta Neurologica Scandinavica, 130, (5) pp. 328-337. ISSN 0001-6314 (2014) [Refereed Article]

DOI: 10.1111/ane.12268 [eCite] [Details]

Citations: Scopus - 26Web of Science - 22

Co-authors: Simpson Jr S; Blizzard L; Pittas F; van der Mei I

Tweet

2014Tettey P, Simpson Jr S, Taylor B, Blizzard L, Ponsonby A-L, et al., 'An adverse lipid profile is associated with disability and progression in disability, in people with MS', Multiple Sclerosis Journal, 20, (13) pp. 1737-1744. ISSN 1477-0970 (2014) [Refereed Article]

DOI: 10.1177/1352458514533162 [eCite] [Details]

Citations: Scopus - 94Web of Science - 89

Co-authors: Tettey P; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2014Tettey P, Simpson Jr S, Taylor B, Blizzard L, Ponsonby A-L, et al., 'Adverse lipid profile is not associated with relapse risk in MS: Results from an observational cohort study', Journal of the Neurological Sciences, 340, (1-2) pp. 230-232. ISSN 1878-5883 (2014) [Refereed Article]

DOI: 10.1016/j.jns.2014.02.038 [eCite] [Details]

Citations: Scopus - 30Web of Science - 30

Co-authors: Tettey P; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2014Tettey P, Simpson Jr S, Taylor BV, van der Mei IAF, 'Vascular comorbidities in the onset and progression of multiple sclerosis', Journal of The Neurological Sciences, 347, (1-2) pp. 23-33. ISSN 0022-510X (2014) [Refereed Article]

DOI: 10.1016/j.jns.2014.10.020 [eCite] [Details]

Citations: Scopus - 62Web of Science - 61

Co-authors: Tettey P; Simpson Jr S; van der Mei IAF

Tweet

2014Zhou Y, Simpson Jr S, Holloway AF, Charlesworth J, van der Mei I, et al., 'The potential role of epigenetic modifications in the heritability of multiple sclerosis', Multiple Sclerosis Journal, 20, (2) pp. 135-140. ISSN 1352-4585 (2014) [Refereed Article]

DOI: 10.1177/1352458514520911 [eCite] [Details]

Citations: Scopus - 24Web of Science - 23

Co-authors: Zhou Y; Simpson Jr S; Holloway AF; Charlesworth J; van der Mei I

Tweet

2014van der Mei IAF, Otahal P, Simpson Jr S, Taylor B, Winzenberg T, 'Meta-analyses to investigate gene-environment interactions in neuroepidemiology', Neuroepidemiology, 42, (1) pp. 39-49. ISSN 0251-5350 (2014) [Refereed Article]

DOI: 10.1159/000355439 [eCite] [Details]

Citations: Scopus - 4Web of Science - 5

Co-authors: van der Mei IAF; Otahal P; Simpson Jr S; Winzenberg T

Tweet

2013Baranzini SE, Khankhanian P, Patsopoulos NA, Li M, Stankovich J, et al., 'Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls', American Journal of Human Genetics: A Record of Research, Review and Bibliographic Material Relating to Heredity in Man, 92, (6) pp. 854-865. ISSN 0002-9297 (2013) [Refereed Article]

DOI: 10.1016/j.ajhg.2013.04.019 [eCite] [Details]

Citations: Scopus - 125Web of Science - 115

Co-authors: Stankovich J

Tweet

2013Beechham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, et al., 'Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis', Nature Genetics, 45, (11) pp. 1353-1360. ISSN 1061-4036 (2013) [Refereed Article]

DOI: 10.1038/ng.2770 [eCite] [Details]

Citations: Scopus - 964Web of Science - 931

Tweet

2013Buck D, Albrecht E, Aslam M, Goris A, Hauenstein N, et al., 'Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis', Annals of Neurology, 73, (1) pp. 86-94. ISSN 0364-5134 (2013) [Refereed Article]

DOI: 10.1002/ana.23749 [eCite] [Details]

Citations: Scopus - 32Web of Science - 29

Co-authors: Stankovich J

Tweet

2013Cortes A, Field J, Glazov EA, Hadler J, Stankovich J, et al., 'Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes', Human Molecular Genetics, 22, (11) pp. 2283-2292. ISSN 0964-6906 (2013) [Refereed Article]

DOI: 10.1093/hmg/ddt062 [eCite] [Details]

Citations: Scopus - 17Web of Science - 14

Co-authors: Stankovich J; Charlesworth J

Tweet

2013Disanto G, Hall C, Lucas R, Ponsonby A-L, Berlanga-Taylor AJ, et al., 'Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis', Multiple Sclerosis, 19, (10) pp. 1355-1358. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513477231 [eCite] [Details]

Citations: Scopus - 13Web of Science - 9

Co-authors: van der Mei I

Tweet

2013Guo S, Lucas RM, Ponsonby A-L, Chapman C, Coulthard A, et al., 'A novel approach for prediction of vitamin D status using support vector regression', PLoS One, 8, (11) Article e79970. ISSN 1932-6203 (2013) [Refereed Article]

DOI: 10.1371/journal.pone.0079970 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: van der Mei I

Tweet

2013Hewer S, Lucas R, van der Mei I, Taylor BV, 'Vitamin D and multiple sclerosis', Journal of Clinical Neuroscience, 20, (5) pp. 634-641. ISSN 0967-5868 (2013) [Refereed Article]

DOI: 10.1016/j.jocn.2012.10.005 [eCite] [Details]

Citations: Scopus - 40Web of Science - 39

Co-authors: van der Mei I

Tweet

2013Hughes A-M, Lucas RM, McMichael AJ, Dwyer T, Pender MP, et al., 'Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially', Clinical and Experimental Immunology, 172, (3) pp. 466-474. ISSN 0009-9104 (2013) [Refereed Article]

DOI: 10.1111/cei.12077 [eCite] [Details]

Citations: Scopus - 14Web of Science - 12

Co-authors: van der Mei I

Tweet

2013Lee SH, Harold D, Nyholt DR, Scott RJ, Lechner-Scott J, et al., 'Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis', Human Molecular Genetics, 22, (4) pp. 832-841. ISSN 0964-6906 (2013) [Refereed Article]

DOI: 10.1093/hmg/dds491 [eCite] [Details]

Citations: Scopus - 152Web of Science - 142

Co-authors: Foote SJ; Stankovich J

Tweet

2013Lin R, Charlesworth J, Stankovich J, Perreau VM, Brown MA, et al., 'Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis', PLoS ONE, 8, (3) Article e56379. ISSN 1932-6203 (2013) [Refereed Article]

DOI: 10.1371/journal.pone.0056379 [eCite] [Details]

Citations: Scopus - 16Web of Science - 15

Co-authors: Charlesworth J; Stankovich J

Tweet

2013Lucas RM, Ponsonby AL, Dear K, Valery PC, Taylor B, et al., 'Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient', Journal of Steroid Biochemistry and Molecular Biology, 136, (13) pp. 300-308. ISSN 0960-0760 (2013) [Refereed Article]

DOI: 10.1016/j.jsbmb.2013.01.011 [eCite] [Details]

Citations: Scopus - 73Web of Science - 71

Co-authors: van der Mei I; Stankovich J

Tweet

2013Lucas RM, Taylor BV, 'Challenges in exposure and outcome definition in neuroepidemiology: the case of vitamin D and multiple sclerosis', Australasian Epidemiologist, 20, (1) pp. 4-8. ISSN 1327-8835 (2013) [Non Refereed Article]

[eCite] [Details]

2013Lucas RM, Valery P, van der Mei I, Dwyer T, Pender MP, et al., 'Sun exposure over a lifetime in Australian adults from latitudinally diverse regions', Photochemistry and Photobiology, 89, (3) pp. 737-744. ISSN 0031-8655 (2013) [Refereed Article]

DOI: 10.1111/php.12044 [eCite] [Details]

Citations: Scopus - 22Web of Science - 20

Co-authors: van der Mei I

Tweet

2013Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, et al., 'A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis', PLoS One, 8, (5) Article e63300. ISSN 1932-6203 (2013) [Refereed Article]

DOI: 10.1371/journal.pone.0063300 [eCite] [Details]

Citations: Scopus - 28Web of Science - 30

Co-authors: Foote S; Stankovich J

Tweet

2013Palmer AJ, Colman S, O'Leary B, Taylor BV, Simmons RD, 'The economic impact of multiple sclerosis in Australia in 2010', Multiple Sclerosis, 19, (12) pp. 1640-1646. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513488230 [eCite] [Details]

Citations: Scopus - 62Web of Science - 53

Co-authors: Palmer AJ

Tweet

2013Palmer AJ, Hitchens PL, Simpson Jr S, O'Leary B, Colman S, et al., 'A novel method for calculating prevalence of multiple sclerosis in Australia', Multiple Sclerosis, 19, (13) pp. 1704-1711. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513479841 [eCite] [Details]

Citations: Scopus - 17Web of Science - 16

Co-authors: Palmer AJ; Hitchens PL; Simpson Jr S

Tweet

2013Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, et al., 'Fine-mapping the genetic association of the major histocompatibility complex in Multiple Sclerosis: HLA and non-HLA effects', PLoS Genetics, 9, (11) Article e1003926. ISSN 1553-7404 (2013) [Refereed Article]

DOI: 10.1371/journal.pgen.1003926 [eCite] [Details]

Citations: Scopus - 200Web of Science - 191

Co-authors: Foote SJ; Stankovich J

Tweet

2013Ponsonby A-L, Lucas RM, Dear K, van der Mei I, Taylor B, et al., 'The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study', Multiple Sclerosis Journal, 19, (13) pp. 1717-1725. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513483887 [eCite] [Details]

Citations: Scopus - 26Web of Science - 22

Co-authors: van der Mei I

Tweet

2013Simpson Jr S, Blizzard L, Taylor B, Tettey P, van der Mei I, 'Is your association real or just reverse causality? Some examples from analyses of multiple sclerosis clinical course and tools to assess it', Australasian Epidemiologist, 20.1 pp. 34-37. ISSN 1327-8835 (2013) [Non Refereed Article]

[eCite] [Details]

Co-authors: Simpson Jr S; Blizzard L; Tettey P; van der Mei I

Tweet

2013Taylor BV, 'Time to onset of secondary progression as an outcome in MS trials: a new paradigm?', Journal of Neurology, Neurosurgery and Psychiatry pp. 1. ISSN 0022-3050 (2013) [Letter or Note in Journal]

DOI: 10.1136/jnnp-2012-304611 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2013Taylor BV, 'Sunshine and multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 84, (10) pp. 1066. ISSN 0022-3050 (2013) [Letter or Note in Journal]

DOI: 10.1136/jnnp-2012-304825 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2013Taylor BV, Palmer A, Simpson Jr S, Lucas R, Simmons RD, et al., 'Assessing possible selection bias in a national voluntary MS longitudinal study in Australia', Multiple Sclerosis, 19, (12) pp. 1627-1631. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513481511 [eCite] [Details]

Citations: Scopus - 49Web of Science - 46

Co-authors: Palmer A; Simpson Jr S

Tweet

2013Toi CS, Lay M-L J, Lucas R, Chew CB, Taylor J, et al., 'Varicella zoster virus quantitation in blood from symptomatic and asymptomatic individuals', Journal of Medical Virology, 85, (8) pp. 1491-1497. ISSN 0146-6615 (2013) [Refereed Article]

DOI: 10.1002/jmv.23605 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: van der Mei I

Tweet

2013Valery PC, Lucas RM, Williams DB, Pender MP, Chapman C, et al., 'Occupational Exposure and Risk of Central Nervous System Demyelination', American Journal of Epidemiology, 177, (9) pp. 954-961. ISSN 0002-9262 (2013) [Refereed Article]

DOI: 10.1093/aje/kws361 [eCite] [Details]

Citations: Scopus - 17Web of Science - 13

Co-authors: van der Mei I

Tweet

2012Curley M, Josey L, Lucas R, Dear K, Taylor BV, et al., 'Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study', Journal of Medical Imaging and Radiation Oncology, 56, (6) pp. 594-598. ISSN 1754-9477 (2012) [Refereed Article]

DOI: 10.1111/1754-9485.12000 [eCite] [Details]

Citations: Scopus - 11Web of Science - 11

Co-authors: van der Mei I

Tweet

2012D'Souza WJ, Quinn SJ, Fryer JL, Taylor BV, Ficker DM, et al., 'The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia', Acta Neurologica Scandinavica, 125, (2) pp. 96-104. ISSN 0001-6314 (2012) [Refereed Article]

DOI: 10.1111/j.1600-0404.2011.01499.x [eCite] [Details]

Citations: Scopus - 12Web of Science - 11

Co-authors: D'Souza WJ; Quinn SJ; Fryer JL

Tweet

2012Josey L, Curley M, Jafari Mousavi F, Taylor BV, Lucas R, et al., 'Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet?', Journal of Medical Imaging and Radiation Oncology, 56, (6) pp. 588-593. ISSN 1754-9477 (2012) [Contribution to Refereed Journal]

DOI: 10.1111/j.1754-9485.2012.02448.x [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Tweet

2012Lai JKC, Lucas RM, Banks E, Ponsonby A-L, Chapman C, et al., 'Variability in vitamin D assays impairs clinical assessment of vitamin D status', Internal Medicine Journal, 42, (1) pp. 43-50. ISSN 1444-0903 (2012) [Refereed Article]

DOI: 10.1111/j.1445-5994.2011.02471.x [eCite] [Details]

Citations: Scopus - 134Web of Science - 130

Co-authors: Van der Mei I

Tweet

2012Lill CM, Liu T, Schjeide B-MM, Roehr JT, Akkad DA, et al., 'Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects', Journal of Medical Genetics, 49, (9) pp. 558-562. ISSN 0022-2593 (2012) [Refereed Article]

DOI: 10.1136/jmedgenet-2012-101175 [eCite] [Details]

Citations: Scopus - 25Web of Science - 26

Co-authors: Drysdale K; Foote SJ

Tweet

2012Lucas RM, Taylor BV, 'Epstein-Barr virus infection: a smoking gun for multiple sclerosis?', Neurology, 79, (13) pp. 1310-1311. ISSN 0028-3878 (2012) [Letter or Note in Journal]

DOI: 10.1212/WNL.0b013e31826c1baf [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2012Ponsonby AL, Lucas RM, van der Mei IA, Dear K, Valery PC, et al., 'Offspring number, pregnancy, and risk of a first clinical demyelinating event: The AusImmune Study', Neurology, 78, (12) pp. 867-874. ISSN 0028-3878 (2012) [Refereed Article]

DOI: 10.1212/WNL.0b013e31824c4648 [eCite] [Details]

Citations: Scopus - 101Web of Science - 100

Co-authors: van der Mei IA

Tweet

2012Richardson AK, Clarke G, Sabel CE, Pearson JF, Mason DF, et al., 'Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register', Internal Medicine Journal, 42, (11) pp. 1207-1212. ISSN 1444-0903 (2012) [Refereed Article]

DOI: 10.1111/j.1445-5994.2012.02754.x [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2012Simpson Jr S, Taylor B, Dwyer DE, Taylor J, Blizzard L, et al., 'Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis', Multiple sclerosis journal, 18, (6) pp. 799-806. ISSN 1477-0970 (2012) [Refereed Article]

DOI: 10.1177/1352458511428081 [eCite] [Details]

Citations: Scopus - 37Web of Science - 36

Co-authors: Simpson Jr S; Blizzard L; Pittas F; Van der Mei I

Tweet

2012Simpson Jr S, Taylor B, van der Mei I, 'A profile of the Multiple Sclerosis Longitudinal Study: Evaluating environmental, behavioural and genetic predictors of clinical outcomes in multiple sclerosis', Australasian Epidemiologist, 19, (2) pp. 33-37. ISSN 1327-8835 (2012) [Non Refereed Article]

[eCite] [Details]

Co-authors: Simpson Jr S; van der Mei I

Tweet

2012Stewart N, Simpson Jr S, van der Mei I, Ponsonby A-L, Blizzard L, et al., 'Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS', Neurology, 79, (3) pp. 254-260. ISSN 0028-3878 (2012) [Refereed Article]

DOI: 10.1212/WNL.0b013e31825fded9 [eCite] [Details]

Citations: Scopus - 78Web of Science - 70

Co-authors: Stewart N; Simpson Jr S; van der Mei I; Blizzard L; Pittas F

Tweet

2012Taylor BV, 'Predicting MS progression: patience is a virtue', Journal of Neurology, Neurosurgery and Psychiatry, 83, (6) pp. 578. ISSN 0022-3050 (2012) [Letter or Note in Journal]

DOI: 10.1136/jnnp-2012-302207 [eCite] [Details]

Tweet

2012Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson JR S, et al., 'Geographical variations in sex ratio trends over time in multiple sclerosis', PLoS ONE, 7, (10) Article e48078. ISSN 1932-6203 (2012) [Refereed Article]

DOI: 10.1371/journal.pone.0048078 [eCite] [Details]

Citations: Scopus - 152Web of Science - 143

Co-authors: Simpson JR S

Tweet

2012Wood B, van der Mei IAF, Ponsonby AL, Pittas F, Quinn S, et al., 'Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis', Multiple Sclerosis, 19, (2) pp. 217-224. ISSN 1352-4585 (2012) [Refereed Article]

DOI: 10.1177/1352458512450351 [eCite] [Details]

Citations: Scopus - 207Web of Science - 192

Co-authors: Wood B; van der Mei IAF; Pittas F

Tweet

2012Yan J, Liu J, Lin CY, Scott RJ, Lechner-Scott J, et al., 'Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis', International Journal of Molecular Sciences, 13, (10) pp. 13667-13679. ISSN 1422-0067 (2012) [Refereed Article]

DOI: 10.3390/ijms131013667 [eCite] [Details]

Citations: Scopus - 16Web of Science - 16

Tweet

2011Hughes AM, Lucas RM, Ponsonby AL, Chapman C, Coulthard A, et al., 'The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study ', Pediatric Allergy and Immunology, 22, (Epub ahead of print 30 September 2010) pp. 327-333. ISSN 0905-6157 (2011) [Refereed Article]

DOI: 10.1111/j.1399-3038.2010.01099.x [eCite] [Details]

Citations: Scopus - 74Web of Science - 74

Co-authors: van der Mei IAF

Tweet

2011Lucas RM, Hughes AM, Lay MLJ, Ponsonby AL, Dwyer DE, et al., 'Epstein-Barr virus and multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 82, (10) pp. 1142-1148. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp-2011-300174 [eCite] [Details]

Citations: Scopus - 80Web of Science - 71

Tweet

2011Lucas RM, Ponsonby AL, Dear K, Valery P, Pender MP, et al., 'Current and past Epstein-Barr virus infection in risk of initial CNS demyelination', Neurology, 77, (4) pp. 371-379. ISSN 0028-3878 (2011) [Refereed Article]

DOI: 10.1212/WNL.0b013e318227062a [eCite] [Details]

Citations: Scopus - 68Web of Science - 59

Co-authors: van der Mei IAF

Tweet

2011Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, et al., 'Sun exposure and vitamin D are independent risk factors for CNS demyelination', Neurology, 76, (6) pp. 540-548 . ISSN 0028-3878 (2011) [Refereed Article]

DOI: 10.1212/WNL.0b013e31820af93d [eCite] [Details]

Citations: Scopus - 282Web of Science - 251

Co-authors: van der Mei I

Tweet

2011Ma GZM, Stankovich J, Bahlo M, Booth DR, Broadley S, et al., 'Polymorphisms in the Receptor Tyrosine Kinase MERTK Gene Are Associated with Multiple Sclerosis Susceptibility', PL o S One, 6, (2) Article e16964. ISSN 1932-6203 (2011) [Refereed Article]

DOI: 10.1371/journal.pone.0016964 [eCite] [Details]

Citations: Scopus - 41Web of Science - 33

Co-authors: Stankovich J; Foote SJ

Tweet

2011O'Gorman C, Freeman S, Taylor BV, Butzkueven H, Broadley SA, 'Familial recurrence risks for multiple sclerosis in Australia', Journal of Neurology, Neurosurgery and Psychiatry, 82, (12) pp. 1351-1354. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp.2010.233064 [eCite] [Details]

Citations: Scopus - 15Web of Science - 15

Tweet

2011Patsopoulos NA, de Bakker PI, Esposito F, Reischl J, Lehr S, et al., 'Genome-Wide Meta-Analysis Identifies Novel Multiple Sclerosis Susceptibility Loci', Annals of Neurology, 70, (6) pp. 897-912. ISSN 0364-5134 (2011) [Refereed Article]

DOI: 10.1002/ana.22609 [eCite] [Details]

Citations: Scopus - 271Web of Science - 260

Co-authors: Foote SJ; Perera D; Stankovich J

Tweet

2011Ritchie ME, Liu R, Carvalho BS, Bahlo M, Booth DR, et al., 'Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips', BMC Bioinformatics, 12 Article 68. ISSN 1471-2105 (2011) [Refereed Article]

DOI: 10.1186/1471-2105-12-68 [eCite] [Details]

Citations: Scopus - 36Web of Science - 41

Co-authors: Foote SJ; Stankovich J; Dickinson JL; Drysdale K; Guru P; Hoban E; McMorran BJ; Polanowski A; Whittock L; Perera D

Tweet

2011Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, et al., 'Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis', Nature, 476, (7359) pp. 214-219. ISSN 0028-0836 (2011) [Refereed Article]

DOI: 10.1038/nature10251 [eCite] [Details]

Citations: Scopus - 2042Web of Science - 1931

Co-authors: Foote SJ; Stankovich J

Tweet

2011Simpson Jr S, Blizzard L, Otahal P, Van der Mei I, Taylor B, 'Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis', Journal of Neurology, Neurosurgery and Psychiatry, 82, (10) pp. 1132-1141. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp.2011.240432 [eCite] [Details]

Citations: Scopus - 469Web of Science - 416

Co-authors: Simpson Jr S; Blizzard L; Otahal P; Van der Mei I

Tweet

2011Simpson S, Pittas F, van der Mei I, Blizzard L, Ponsonby AL, et al., 'Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009', Journal of Neurology, Neurosurgery and Psychiatry, 82, (2) pp. 180-187. ISSN 0022-3050 (2011) [Refereed Article]

DOI: 10.1136/jnnp.2010.215186 [eCite] [Details]

Citations: Scopus - 47Web of Science - 41

Co-authors: Simpson S; Pittas F; van der Mei I; Blizzard L

Tweet

2011Taylor BV, 'Ireland: a fine place for multiple sclerosis research', Journal of Neurology, Neurosurgery and Psychiatry, 82, (3) pp. 237. ISSN 0022-3050 (2011) [Non Refereed Article]

DOI: 10.1136/jnnp.2010.234237 [eCite] [Details]

Tweet

2011Van der Walt A, Stankovich J, Bahlo M, Taylor BV, Van der Mei IAF, et al., 'Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition ', Multiple Sclerosis, 17, (3) pp. 344-352. ISSN 1352-4585 (2011) [Refereed Article]

DOI: 10.1177/1352458510389101 [eCite] [Details]

Citations: Scopus - 32Web of Science - 31

Co-authors: Stankovich J; Van der Mei IAF; Foote SJ

Tweet

2011Wang JH, Pappas D, De Jager P, Pelletier D, de Bakker PIW, et al., 'Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data', Genome Medicine, 3 Article 3. ISSN 1756-994X (2011) [Refereed Article]

DOI: 10.1186/gm217 [eCite] [Details]

Citations: Scopus - 51Web of Science - 49

Co-authors: Foote SJ; Stankovich J

Tweet

2010Bahlo M, Stankovich J, Danoy P, Hickey PF, Taylor BV, et al., 'Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies', Cancer Epidemiology, Biomarkers and Prevention, 19, (3) pp. 794-798. ISSN 1055-9965 (2010) [Refereed Article]

DOI: 10.1158/1055-9965.EPI-09-0812 [eCite] [Details]

Citations: Scopus - 44Web of Science - 41

Co-authors: Stankovich J; Foote SJ; Dickinson JL; Drysdale K; Guru P; Hoban E; McMorran BJ; Polanowski A; Whittock L; Perera D

Tweet

2010Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, et al., 'MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood', P L o S One, 5, (8) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0012132 [eCite] [Details]

Citations: Scopus - 202Web of Science - 485

Co-authors: Foote SJ; Stankovich J

Tweet

2010Field J, Browning SR, Johnson LJ, Danoy P, Varney MD, et al., 'A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis', PLoS ONE, 5, (10) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0013454 [eCite] [Details]

Citations: Scopus - 46Web of Science - 42

Co-authors: Charlesworth JC; Foote SJ; Stankovich J

Tweet

2010Gandhi KS, McKay FC, Cox M, Riveros C, Armstrong N, et al., 'The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis ', Human Molecular Genetics, 19, (11) pp. 2134-2143. ISSN 0964-6906 (2010) [Refereed Article]

DOI: 10.1093/hmg/ddq090 [eCite] [Details]

Citations: Scopus - 102Web of Science - 95

Co-authors: Stankovich J; Foote SJ

Tweet

2010Jensen CJ, Stankovich J, Van der Walt A, Bahlo M, Taylor BV, et al., 'Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients', P L o S One, 5, (4) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0010003 [eCite] [Details]

Citations: Scopus - 42Web of Science - 41

Co-authors: Stankovich J; van der Mei IAF; Foote SJ

Tweet

2010Lay ML, Lucas RM, Ratnamohan M, Taylor J, Ponsonby AL, et al., 'Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye ', Virology Journal, 7, (252) EJ ISSN 1743-422X (2010) [Refereed Article]

DOI: 10.1186/1743-422X-7-252 [eCite] [Details]

Citations: Scopus - 31Web of Science - 27

Co-authors: van der Mei I

Tweet

2010Riveros C, Mellor D, Gandhi KS, McKay FC, Cox MB, et al., 'A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in Multiple Sclerosis ', P L o S One, 5, (12) EJ ISSN 1932-6203 (2010) [Refereed Article]

DOI: 10.1371/journal.pone.0014176 [eCite] [Details]

Citations: Scopus - 45Web of Science - 42

Co-authors: Foote SJ; Stankovich J

Tweet

2010Simpson S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, et al., 'Higher 25-hydroxyvitamin D is associated with lower relapse risk in Multiple Sclerosis', Annals of Neurology, 68, (2) pp. 193-203. ISSN 0364-5134 (2010) [Refereed Article]

DOI: 10.1002/ana.22043 [eCite] [Details]

Citations: Scopus - 387Web of Science - 358

Co-authors: Simpson S; Blizzard L; Pittas F; van der Mei I

Tweet

2010Taylor BV, Lucas RM, Dear K, Kilpatrick TJ, Pender MP, et al., 'Latitudinal variation in incidence and type of first central nervous system demyelinating events', Multiple Sclerosis, 16, (4) pp. 398-405. ISSN 1352-4585 (2010) [Refereed Article]

DOI: 10.1177/1352458509359724 [eCite] [Details]

Citations: Scopus - 81Web of Science - 72

Co-authors: van der Mei IAF

Tweet

2010Taylor BV, Pearson JF, Clarke G, Mason DF, Abernethy DA, et al., 'MS prevalence in New Zealand, an ethnically and latitudinally diverse country ', Multiple Sclerosis, 16, (12) pp. 1422-1431. ISSN 1352-4585 (2010) [Refereed Article]

DOI: 10.1177/1352458510379614 [eCite] [Details]

Citations: Scopus - 78Web of Science - 73

Tweet

2010van der Mei IAF, Ponsonby AL, Taylor BV, Stankovich J, Dickinson JL, et al., 'Human Leukocyte Antigen-DR15, Low Infant Sibling Exposure and Multiple Sclerosis: Gene-Environment Interaction', Annals of Neurology, 67, (2) pp. 261-265. ISSN 0364-5134 (2010) [Refereed Article]

DOI: 10.1002/ana.21849 [eCite] [Details]

Citations: Scopus - 20Web of Science - 20

Co-authors: van der Mei IAF; Ponsonby AL; Stankovich J; Dickinson JL; Foote S; Dwyer T

Tweet

2009Bahlo M, Booth DR, Broadley SA, Brown MA, Foote SJ, et al., 'Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20', Nature Genetics, 41, (7) pp. 824-830. ISSN 1061-4036 (2009) [Refereed Article]

DOI: 10.1038/ng.396 [eCite] [Details]

Citations: Scopus - 460Web of Science - 395

Co-authors: Foote SJ; Stankovich J; Drysdale KE; Mayura Guru P; McMorran BJ; Perera DI

Tweet

2009Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, et al., 'Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction ', Multiple Sclerosis, 15, (5) pp. 563-570. ISSN 1352-4585 (2009) [Refereed Article]

DOI: 10.1177/1352458509102459 [eCite] [Details]

Citations: Scopus - 78Web of Science - 71

Co-authors: Dickinson JL; Perera DI; van der Mei AF; Ponsonby AL; Polanowski AM; Thomson RJ; Stankovich J; Dwyer T

Tweet

2009Lucas RM, Ponsonby AL, Dear K, Taylor BV, Dwyer T, et al., 'Associations between Silicone Skin Cast Score, Cumulative Sun Exposure, and Other Factors in the Ausimmune Study: A Multicenter Australian Study ', Cancer Epidemiology, Biomarkers and Prevention, 18, (11) pp. 2887-2894. ISSN 1055-9965 (2009) [Refereed Article]

DOI: 10.1158/1055-9965 [eCite] [Details]

Citations: Scopus - 43Web of Science - 41

Co-authors: Van der Mei IAF

Tweet

2009Perera DI, Stankovich J, Butzkueven H, Taylor BVM, Foote SJ, et al., 'Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus', Journal of Neuroimmunology, 211, (25) pp. 105-109. ISSN 0165-5728 (2009) [Refereed Article]

DOI: 10.1016/j.jneuroim.2009.03.010 [eCite] [Details]

Citations: Scopus - 24Web of Science - 24

Co-authors: Perera DI; Stankovich J; Foote SJ

Tweet

2009Pittas F, Ponsonby AL, Van der Mei IAF, Taylor BVM, Blizzard CL, et al., 'Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis ', Journal of Neurology: Official Journal of The European Neurological Society, 256, (4) pp. 577-585. ISSN 0340-5354 (2009) [Refereed Article]

DOI: 10.1007/s00415-009-0120-2 [eCite] [Details]

Citations: Scopus - 104Web of Science - 102

Co-authors: Pittas F; Ponsonby AL; Van der Mei IAF; Blizzard CL; Groom PS; Dwyer T

Tweet

2009Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, et al., 'HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis', Tissue Antigens, 74, (1) pp. 17-21. ISSN 0001-2815 (2009) [Refereed Article]

DOI: 10.1111/j.1399-0039.2009.01262.x [eCite] [Details]

Citations: Scopus - 38Web of Science - 33

Co-authors: Stankovich J; Foote SJ

Tweet

2009Young J, Quinn S, Hurrell M, Taylor B, 'Clinically isolated acute transverse myelitis: prognostic features and incidence', Multiple Sclerosis, 15, (11) pp. 1295-1302. ISSN 1352-4585 (2009) [Refereed Article]

DOI: 10.1177/1352458509345906 [eCite] [Details]

Citations: Scopus - 48Web of Science - 38

Tweet

2009Young JW, Mason DF, Taylor BV, 'Acute inflammatory encephalomyelitis following Campylobacter enteritis associated with high titre antiganglioside GM1 IgG antibodies', Journal of Clinical Neuroscience, 16, (4) pp. 597-598. ISSN 0967-5868 (2009) [Refereed Article]

DOI: 10.1016/j.jocn.2008.05.028 [eCite] [Details]

Citations: Scopus - 3Web of Science - 1

Tweet

2009van der Walt A, Stankovich J, Bahlo M, Taylor BV, van der Mei IAF, et al., 'Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy', Neurology, 73, (13) pp. 1018-1025. ISSN 0028-3878 (2009) [Refereed Article]

DOI: 10.1212/WNL.0b013e3181b9c85e [eCite] [Details]

Citations: Scopus - 39Web of Science - 33

Co-authors: Stankovich J; van der Mei IAF; Foote SJ

Tweet

2008Arthur AT, Armati PJ, Bye C, Kilpatrick TJ, Foote SJ, et al., 'Genes implicated in multiple sclerosis pathogenesis fromconsilience of genotyping and expression profiles in relapse and remission', BMC Medical Genetics, 9, (Mar 19) pp. 17. ISSN 1471-2350 (2008) [Refereed Article]

DOI: 10.1186/1471-2350-9-17 [eCite] [Details]

Citations: Scopus - 51Web of Science - 51

Co-authors: Foote SJ; Stankovich J

Tweet

2008Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, et al., 'SNP mapping and candidate gene sequencing in the class 1 region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians', Tissue Antigens, 71, (Oct 30) pp. 42-50. ISSN 0001-2815 (2008) [Refereed Article]

DOI: 10.1111/j.1399-0039.2007.00962.x [eCite] [Details]

Citations: Scopus - 45Web of Science - 43

Co-authors: Stankovich J; Foote SJ

Tweet

2008Butzkueven H, Kolbe SC, Jolley DJ, Brown JY, Cook MJ, et al., 'Validation of linear cerebral atrophy markers in multiple sclerosis', Journal of Clinical Neuroscience, 15, (2) pp. 130-137. ISSN 0967-5868 (2008) [Refereed Article]

DOI: 10.1016/jjocn.2007.02.089 [eCite] [Details]

Citations: Scopus - 38Web of Science - 38

Co-authors: Van der Mei IAF; Groom PS

Tweet

2008D'Souza WJ, Fryer JL, Quinn SJ, Taylor BVM, Ficker DM, et al., 'The Tasmanian Epilepsy Register - A Community-Based Cohort: Background and methodology for patient recruitment from the Australian national prescription database', Neuroepidemiology, 29, (3-4) pp. 255-263. ISSN 0251-5350 (2008) [Refereed Article]

DOI: 10.1159/000112859 [eCite] [Details]

Citations: Scopus - 19Web of Science - 20

Co-authors: D'Souza WJ; Fryer JL; Quinn SJ

Tweet

2008Dwyer T, Van der Mei IAF, Ponsonby AL, Taylor BVM, Stankovich J, et al., 'Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis', Neurology, 71, (8) pp. 583-589. ISSN 0028-3878 (2008) [Refereed Article]

DOI: 10.1212/01.wnl.0000323928.57408.93 [eCite] [Details]

Citations: Scopus - 39Web of Science - 37

Co-authors: Dwyer T; Van der Mei IAF; Ponsonby AL; Stankovich J; Thomson Russell; Polanowski AM; Dickinson JL

Tweet

2008Husain S, Yildirim-Toruner C, Rubio JP, Field J, Kilpatrick TJ, et al., 'Variants of ST8SIA1 Are Associated with Risk of Developing Multiple Sclerosis', PLoS One, 3, (7) pp. e2653. ISSN 1932-6203 (2008) [Refereed Article]

DOI: 10.1371/journal.pone.0002653 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Foote SJ; Stankovich J

Tweet

2008Murphy M, Quinn SJ, Young J, Parkin P, Taylor BVM, 'Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study', Neurology, 71, (23) pp. 1889-1895. ISSN 0028-3878 (2008) [Refereed Article]

DOI: 10.1212/01.wnl.0000336653.65605.ac [eCite] [Details]

Citations: Scopus - 89Web of Science - 80

Co-authors: Quinn SJ

Tweet

2008Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, et al., 'Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians', Genes and Immunity, 9, (7) pp. 624-630. ISSN 1466-4879 (2008) [Refereed Article]

DOI: 10.1038/gene.2008.59 [eCite] [Details]

Citations: Scopus - 104Web of Science - 98

Co-authors: Stankovich J; Perera DI; Foote SJ

Tweet

2008Tremlett H, Van der Mei IAF, Pittas F, Blizzard CL, Paley GA, et al., 'Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses', Pharmacoepidemiology and Drug Safety, 17, (6) pp. 565-576. ISSN 1053-8569 (2008) [Refereed Article]

DOI: 10.1002/pds.1593 [eCite] [Details]

Citations: Scopus - 64Web of Science - 63

Co-authors: Van der Mei IAF; Pittas F; Blizzard CL; Paley GA

Tweet

2008Tremlett H, Van der Mei IAF, Pittas F, Blizzard CL, Paley GA, et al., 'Monthly ambient sunlight, infections and relapse rates in multiple sclerosis', Neuroepidemiology, 31, (4) pp. 271-279. ISSN 0251-5350 (2008) [Refereed Article]

DOI: 10.1159/000166602 [eCite] [Details]

Citations: Scopus - 127Web of Science - 116

Co-authors: Van der Mei IAF; Pittas F; Blizzard CL; Paley GA; Mesaros D; Wood-Baker R; Nunez M; Dwyer T; Ponsonby AL

Tweet

2008Wray BN, Stankovich J, Whittock LD, Dwyer T, Ponsonby AL, et al., 'CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population', Journal of Neuroimmunology, 196, (1-2) pp. 139-142. ISSN 0165-5728 (2008) [Refereed Article]

DOI: 10.1016/j.jneuroim.2008.02.001 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Wray BN; Stankovich J; Whittock LD; Van der Mei IAF; Dickinson JL; Foote SJ; McMorran BJ

Tweet

2007Lucas RM, Ponsonby AL, McMichael AJ, Van der Mei IAF, Chapman C, et al., 'Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function', Multiple Sclerosis, 13, (7) pp. 827-839. ISSN 1352-4585 (2007) [Refereed Article]

DOI: 10.1177/1352458507077174 [eCite] [Details]

Citations: Scopus - 55Web of Science - 53

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T

Tweet

2007Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, et al., 'Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class 1 region in Tasmanian MS patients', Immunogenetics, 59, (3) pp. 177-186. ISSN 0093-7711 (2007) [Refereed Article]

DOI: 10.1007/s00251-006-0183-5 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Stankovich J; Foote SJ

Tweet

2007Stewart NJ, Taylor BVM, Ponsonby AL, Pittas F, Van der Mei IAF, et al., 'The effect of season on cytokine expression in multiple sclerosis and healthy subjects', Journal of Neuroimmunology, 188, (1-2) pp. 181-186. ISSN 0165-5728 (2007) [Refereed Article]

DOI: 10.1016/j.jneuroim.2007.06.012 [eCite] [Details]

Citations: Scopus - 23Web of Science - 22

Co-authors: Stewart NJ; Ponsonby AL; Pittas F; Van der Mei IAF; Woods GM; Walters EH

Tweet

2007Taylor BV, McDonald E, Fantino B, Sedal L, MacDonnell R, et al., 'The cost of multiple sclerosis in Australia ', Journal of Clinical Neuroscience, 14, (6) pp. 532-539. ISSN 0967-5868 (2007) [Refereed Article]

DOI: 10.1016/j.jocn.2006.08.007 [eCite] [Details]

Citations: Scopus - 26Web of Science - 24

Tweet

2007Taylor BV, Williamson J, Jones D, Coleman D, Luck J, et al., 'Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease', Journal of Clinical Neuroscience, 14, (2) pp. 116-121. ISSN 0967-5868 (2007) [Refereed Article]

DOI: 10.1016/j.jocn.2006.01.040 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Tweet

2007Van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard CL, Taylor BV, et al., 'Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia', Journal of Neurology, 254, (5) pp. 581-590. ISSN 0340-5354 (2007) [Refereed Article]

DOI: 10.1007/s00415-006-0315-8 [eCite] [Details]

Citations: Scopus - 269Web of Science - 245

Co-authors: Van der Mei IAF; Ponsonby AL; Dwyer T; Blizzard CL

Tweet

2006Lowenthal RM, Taylor BV, Jones R, Beasley A, 'Severe persistent sciatic pain and weakness due to a gluteal artery pseudoaneurysm as a complication of bone marrow biopsy', Journal of Clinical Neuroscience, 13, (3) pp. 384-385. ISSN 0967-5868 (2006) [Refereed Article]

DOI: 10.1016/j.jocn.2005.03.027 [eCite] [Details]

Citations: Scopus - 14Web of Science - 12

Co-authors: Lowenthal RM; Jones R; Beasley A

Tweet

2006Mujic A, Hunn AWM, Taylor BV, Lowenthal RM, 'Extracranial metastases of a glioblastoma multiforme to the pleura, small bowel and pancreas', Journal of Clinical Neuroscience, 13, (6) pp. 677-681. ISSN 0967-5868 (2006) [Refereed Article]

DOI: 10.1016/j.jocn.2005.08.016 [eCite] [Details]

Citations: Scopus - 26Web of Science - 27

Tweet

2006Ponsonby AL, Dwyer T, Van der Mei IAF, Kemp A, Blizzard CL, et al., 'Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life', Clinical and Experimental Immunology, 146, (3) pp. 463-470. ISSN 0009-9104 (2006) [Refereed Article]

DOI: 10.1111/j.1365-2249.2006.03235.x [eCite] [Details]

Citations: Scopus - 31Web of Science - 33

Co-authors: Ponsonby AL; Dwyer T; Van der Mei IAF; Blizzard CL

Tweet

2006Taylor BV, 'Diabetic nerve vulnerability to ischaemia', Journal Watch Neurology, 8 pp. 51-52. ISSN 1524-0207 (2006) [Contribution to Refereed Journal]

[eCite] [Details]

2005Ostberg A, Pittas F, Taylor BVM, 'Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status', Internal Medicine Journal, 35, (7) pp. 382-387. ISSN 1444-0903 (2005) [Refereed Article]

DOI: 10.1111/j.1445-5994.2005.00862.x [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Pittas F

Tweet

2005Ponsonby AL, Van der Mei IAF, Dwyer T, Blizzard CL, Taylor BV, et al., 'Birth order, infection in early life, and multiple sclerosis', The Lancet Neurology, 4, (12) pp. 793-794. ISSN 1474-4422 (2005) [Contribution to Refereed Journal]

DOI: 10.1016/S1474-4422(05)70233-7 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T; Blizzard CL

Tweet

2005Ponsonby AL, Van der Mei IAF, Dwyer T, Blizzard CL, Taylor BVM, et al., 'Exposure to infant siblings during early life and risk of multiple sclerosis: reply to Ruprecht and Peron', Journal of the American Medical Association, 293, (17) pp. 2089-2090. ISSN 0098-7484 (2005) [Letter or Note in Journal]

DOI: 10.1001/jama.293.17.2089-a [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T; Blizzard CL

Tweet

2005Ponsonby AL, Van der Mei IAF, Dwyer T, Blizzard CL, Taylor BVM, et al., 'Exposure to infant siblings during early life and risk of multiple sclerosis', Journal of the American Medical Association, 293, (4) pp. 463-469. ISSN 0098-7484 (2005) [Refereed Article]

DOI: 10.1001/jama.293.4.463 [eCite] [Details]

Citations: Scopus - 135Web of Science - 119

Co-authors: Ponsonby AL; Van der Mei IAF; Dwyer T; Blizzard CL

Tweet

2005Sinnreich M, Taylor BV, Dyck P, 'Diabetic neuropathies. Classification, clinical features, and pathophysiological basis', The Neurologist, 11, (2) pp. 63-79. ISSN 1074-7931 (2005) [Refereed Article]

DOI: 10.1097/01.nrl.0000156314.24508.ed [eCite] [Details]

Citations: Scopus - 144Web of Science - 124

Tweet

2004Kilpatrick TJ, Butzkueven H, Emery B, Marriott M, Taylor BV, et al., 'Neuroglial responses to CNS injury: prospects for novel therapeutics', Expert Review of Neurotherapeutics, 4, (5) pp. 869-878. ISSN 1744-8360 (2004) [Refereed Article]

DOI: 10.1586/14737175.4.5.869 [eCite] [Details]

Citations: Scopus - 3

Tweet

2004Rubio JP, Bahlo M, Tubridy N, Stankovich J, Burfoot R, et al., 'Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis', Human Genetics, 114, (6) pp. 573-580. ISSN 0340-6717 (2004) [Refereed Article]

DOI: 10.1007/s00439-004-1095-9 [eCite] [Details]

Citations: Scopus - 39Web of Science - 33

Co-authors: Stankovich J; Foote SJ

Tweet

2004Taylor BV, Dunne JW, 'Diabetic amyotrophy progressing to severe quadriparesis', Muscle & Nerve, 30, (4) pp. 505-509. ISSN 0148-639X (2004) [Refereed Article]

DOI: 10.1002/mus.20107 [eCite] [Details]

Citations: Scopus - 9Web of Science - 7

Tweet

2004Taylor BV, Dyck PJB, Engelstad J, Gruener G, Grant I, et al., 'Multifocal motor neuropathy: pathologic alterations at the site of conduction block', Journal of Neuropathology and Experimental Neurology, 63, (2) pp. 129-137. ISSN 0022-3069 (2004) [Refereed Article]

DOI: 10.1093/jnen/63.2.129 [eCite] [Details]

Citations: Scopus - 105Web of Science - 85

Tweet

2004Taylor BV, Williamson J, Luck J, Coleman D, Jones D, et al., 'Sensitivity and specificity of serology in determining recent acute Campylobacter infection', Internal Medicine Journal, 34, (5) pp. 250-258. ISSN 1444-0903 (2004) [Refereed Article]

DOI: 10.1111/j.1444-0903.2004.00517.x [eCite] [Details]

Citations: Scopus - 22Web of Science - 21

Tweet

2003Hancock N, Poon M, Taylor BV, McLean C, 'Hereditary diffuse leucoencephalopathy with spheroids', Journal of Neurology, Neurosurgery and Psychiatry, 74, (9) pp. 1345-1347. ISSN 0022-3050 (2003) [Refereed Article]

DOI: 10.1136/jnnp.74.9.1345 [eCite] [Details]

Citations: Scopus - 35Web of Science - 33

Tweet

2003Kagerer FA, Summers JJ, Byblow WD, Taylor B, 'Altered Corticomotor Representation in Patients with Parkinson's Disease', Movement Disorders, 18, (8) pp. 919-927. ISSN 0885-3185 (2003) [Refereed Article]

DOI: 10.1002/mds.10452 [eCite] [Details]

Citations: Scopus - 13Web of Science - 11

Co-authors: Kagerer FA; Summers JJ

Tweet

2003Mujic A, Hunn AWM, Liddell J, Taylor BV, Havlat M, et al., 'Isolated unilateral hypoglossal nerve paralysis caused by an atlanto-occipital joint synovial cyst', Journal of Clinical Neuroscience, 10, (4) pp. 492-495. ISSN 0967-5868 (2003) [Refereed Article]

DOI: 10.1016/S0967-5868(03)00083-3 [eCite] [Details]

Citations: Scopus - 23Web of Science - 26

Co-authors: Hunn AWM; Liddell J; Havlat M

Tweet

2003Van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard CL, Simmons R, et al., 'Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study', British Medical Journal, 327, (7410) pp. 316-320. ISSN 0959-535X (2003) [Refereed Article]

DOI: 10.1136/bmj.327.7410.316 [eCite] [Details]

Citations: Scopus - 458Web of Science - 389

Co-authors: Van der Mei IAF; Ponsonby AL; Dwyer T; Blizzard CL

Tweet

2002Rubio J, Bahlo M, Butzkueven H, Van der Mei IAF, Sale MM, et al., 'Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis', American Journal of Human Genetics, 70, (5) pp. 1125-1137. ISSN 0002-9297 (2002) [Refereed Article]

DOI: 10.1086/339932 [eCite] [Details]

Citations: Scopus - 85Web of Science - 78

Co-authors: Van der Mei IAF; Sale MM; Dickinson JL; Groom PS; Dwyer T; Foote SJ

Tweet

2001Taylor BV, 'Grand rounds a 24 year old man with upper limb weakness, pain and sensory loss. Case report and comments', Journal of The Neuromusculoskeletal System, 9, (3) pp. 103-107. ISSN 1067-8239 (2001) [Refereed Article]

[eCite] [Details]

2000Lowenthal RM, Taylor BV, Tan BS, 'Cold sweat case report', The Lancet, 356, (16 December) pp. 2064. ISSN 0140-6736 (2000) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Lowenthal RM

2000Taylor BV, Wright RA, Harper CM, Dyck PJ, 'Natural history of 46 patients with multifocal motor neuropathy with conduction block', Muscle and Nerve, 23, (6) pp. 900-908. ISSN 0148-639X (2000) [Refereed Article]

DOI: 10.1002/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y [eCite] [Details]

Citations: Web of Science - 124

Tweet

1998Go RS, Taylor BV, Kimmel DW, 'The natural history of asymptomatic meningiomas in Olmsted County, Minnesota', Neurology, 51, (6) pp. 1718-1720. ISSN 0028-3878 (1998) [Refereed Article]

DOI: 10.1212/WNL.51.6.1718 [eCite] [Details]

Citations: Scopus - 66Web of Science - 49

Tweet

1998Taylor BV, Buckner JC, Cascino TL, O'Fallon JR, Schaefer PL, et al., 'Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma', Journal of Clinical Oncology, 16, (6) pp. 2195-2201 . ISSN 0732-183X (1998) [Refereed Article]

DOI: 10.1200/JCO.1998.16.6.2195 [eCite] [Details]

Citations: Scopus - 87Web of Science - 79

Tweet

1998Taylor BV, Phillips BA, Speed BR, Kaldor J, Carroll WM, et al., 'Serological evidence for infection with Campylobacter jejuni/coli in patients with multifocal motor neuropathy', Journal of Clinical Neuroscience, 5, (1) pp. 33-35. ISSN 0967-5868 (1998) [Refereed Article]

DOI: 10.1016/S0967-5868(98)90198-9 [eCite] [Details]

Citations: Scopus - 8Web of Science - 6

Tweet

1997Taylor BV, Kimmel DW, Krecke KN, Cascino TL, 'Magnetic resonance imaging in cancer-related lumbosacral plexopathy', Mayo Clinic Proceedings, 72, (9) pp. 823-829. ISSN 0025-6196 (1997) [Refereed Article]

DOI: 10.4065/72.9.823 [eCite] [Details]

Citations: Scopus - 74Web of Science - 48

Tweet

1996Taylor BV, Gross L, Windebank AJ, 'The sensitivity and specificity of anti-GM1 antibody testing ', Neurology, 47, (4) pp. 951-955 . ISSN 0028-3878 (1996) [Refereed Article]

DOI: 10.1212/WNL.47.4.951 [eCite] [Details]

Citations: Scopus - 112Web of Science - 98

Tweet

1995Kermode AG, Ives FJ, Taylor B, Davis SJ, Carroll WM, 'Progressive dural venous sinus thrombosis treated with local streptokinase infusion', Journal of Neurology, Neurosurgery and Psychiatry, 58, (1) pp. 107-108. ISSN 0022-3050 (1995) [Letter or Note in Journal]

[eCite] [Details]

1995Taylor BV, Mastaglia FL, Stell R, 'Guillain-Barre syndrome complicating treatment with streptokinase', Medical Journal of Australia, 162, (4) pp. 214-215. ISSN 0025-729X (1995) [Refereed Article]

DOI: 10.5694/j.1326-5377.1995.tb126028.x [eCite] [Details]

Citations: Web of Science - 5

Tweet

1995Taylor BV, Wijdicks EF, Poterucha JJ, Weisner RH, 'Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation', Annals of Neurology, 38, (5) pp. 828-831. ISSN 0364-5134 (1995) [Refereed Article]

DOI: 10.1002/ana.410380519 [eCite] [Details]

Citations: Scopus - 27Web of Science - 20

Tweet

1994Anderson CS, Taylor BV, Hankey GJ, Stewart-Wynne EG, Jamrozik KD, 'Validation of a clinical classification for subtypes of acute cerebral infarction', Journal of Neurology, Neurosurgery and Psychiatry, 57, (10) pp. 1173-1179. ISSN 0022-3050 (1994) [Refereed Article]

DOI: 10.1136/jnnp.57.10.1173 [eCite] [Details]

Citations: Scopus - 73Web of Science - 58

Tweet

Chapter in Book

(1 outputs)
YearCitationAltmetrics
2003Taylor BV, 'The Treatment of Multifocal Motor Neuropathy with Conduction Block (MMN-CB)', Neurological Therapeutics: Principles and Practice, Martin Dunitz, Noseworthy JH (ed), London and New York, pp. 2111-2116. ISBN 1-85317-623-0 (2003) [Other Book Chapter]

[eCite] [Details]

Review

(6 outputs)
YearCitationAltmetrics
2012Lin R, Charlesworth J, van der Mei I, Taylor BV, 'The genetics of multiple sclerosis', Practical Neurology, 12, (5) pp. 279-288. ISSN 1474-7758 (2012) [Substantial Review]

DOI: 10.1136/practneurol-2012-000276 [eCite] [Details]

Citations: Scopus - 33

Co-authors: Charlesworth J; van der Mei I

Tweet

2012O'Gorman C, Lucas R, Taylor B, 'Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms', International Journal of Molecular Sciences, 13, (9) pp. 11718-11752. ISSN 1422-0067 (2012) [Substantial Review]

DOI: 10.3390/ijms130911718 [eCite] [Details]

Citations: Scopus - 135Web of Science - 115

Tweet

2011Simpson Jr S, Greenhill K, Van der Mei I, Stankovich J, Charlesworth J, et al., 'The Varied Mechanisms of Vitamin D in the Onset and Clinical Course of MS: Potential Roles in Modulating Other Etiological Pathways', Current Medical Literature. Neurology, 27, (1) pp. 1-14. (2011) [Substantial Review]

[eCite] [Details]

Co-authors: Simpson Jr S; Greenhill K; Van der Mei I; Stankovich J; Charlesworth J

2011Taylor BV, 'The major cause of multiple sclerosis is environmental: genetics has a minor role - Yes', Multiple Sclerosis Journal, 17, (10) pp. 1171-1173. (2011) [Substantial Review]

DOI: 10.1177/1352458511421105 [eCite] [Details]

Citations: Scopus - 25Web of Science - 20

Tweet

2011Van der Mei IAF, Simpson JR S, Knippenberg S, Winzenberg T, Taylor BV, 'Role of vitamin D in multiple sclerosis: implications for disease management', Neurodegenerative Disease Management, 1, (6) pp. 523-536. (2011) [Substantial Review]

DOI: 10.2217/NMT.11.59 [eCite] [Details]

Co-authors: Van der Mei IAF; Simpson JR S; Winzenberg T

Tweet

2011Van der Mei IAF, Simpson Jr S, Stankovich J, Taylor BV, 'Individual and Joint Action of Environmental Factors and Risk of MS', Neurologic Clinics , 29, (2) pp. 233-255. (2011) [Substantial Review]

DOI: 10.1016/j.ncl.2010.12.007 [eCite] [Details]

Citations: Scopus - 57Web of Science - 46

Co-authors: Van der Mei IAF; Simpson Jr S; Stankovich J

Tweet

Conference Publication

(41 outputs)
YearCitationAltmetrics
2022Campbell JA, Ahmad H, Chen G, Claflin S, Taylor BV, et al., 'Investigating health-related quality of life impacts for participants of the Australian MS Longitudinal Study using the new EQ-5D-5L Psychosocial instrument', Multiple Sclerosis Journal, pp. 18-19. ISSN 1352-4585 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Campbell JA; Ahmad H; Claflin S; van der Mei I; Laslett L; Henson G; Palmer AJ

2022Campbell JA, Ahmad H, Claflin S, Taylor BV, van der Mei I, et al., 'Assessing health-related quality-of-life in Australian Multiple Sclerosis Longitudinal Study participants using six multi-attribute utility instruments: implications for healthcare decision-making', Multiple Sclerosis Journal, pp. 19. ISSN 1352-4585 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Campbell JA; Ahmad H; Claflin S; van der Mei I; Laslett L; Henson G; Palmer AJ

2022Claflin S, Campbell J, Bessing B, van der Mei I, Palmer AJ, et al., 'Knowledge translation in the international MS community: an evaluation of the Understanding Multiple Sclerosis free online course', Multiple Sclerosis Journal, pp. 19. ISSN 1352-4585 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Claflin S; Campbell J; Bessing B; van der Mei I; Palmer AJ

2022Henson G, van der Mei I, Taylor B, Blacklow P, Claflin SB, et al., 'The impact of the COVID-19 pandemic and lockdowns on the health-related quality of life of people living with multiple sclerosis in Australia', Value in Health, July 2022 ISSN 1098-3015 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Henson G; van der Mei I; Blacklow P; Claflin SB; Palmer AJ; Hurst C; Campbell JA

2021Bessing B, Blizzard L, Hussain MA, Claflin SB, Taylor BV, et al., 'Longitudinal trends of work productivity in a representative sample of Australians living with multiple sclerosis', International Journal of Epidemiology, pp. i29-i30. ISSN 0300-5771 (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Bessing B; Blizzard L; Hussain MA; Claflin SB; van der Mei I

Tweet

2021Bessing B, Honan CA, van der Mei I, Taylor BV, Claflin SB, 'Rasch analysis of the Health Literacy Questionnaire in the Understanding Multiple Sclerosis online course cohort', International Journal of Epidemiology, pp. i30. ISSN 0300-5771 (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Bessing B; Honan CA; van der Mei I; Claflin SB

2021Bessing B, Hussain MA, Blizzard L, Claflin SB, Taylor BV, et al., 'Work productivity trajectories in a representative sample of Australians living with multiple sclerosis group-based modelling', International Journal of Epidemiology, pp. i30. ISSN 0300-5771 (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Bessing B; Hussain MA; Blizzard L; Claflin SB; van der Mei I

Tweet

2021Zarghami A, Hussain MA, van der Mei I, Claflin SB, Bessing B, et al., 'Long Term Trajectories of Employment Status Work Hours and Disability Pension Status After an Initial Episode CNS Demyelination', Multiple Sclerosis Journal, pp. 57-58. ISSN 1352-4585 (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Zarghami A; Hussain MA; van der Mei I; Claflin SB; Bessing B

2020Bessing B, Claflin S, Hussain M, Chen J, Blizzard L, et al., 'Work based trajectories in Australians living with with multiple sclerosis: a group-based modelling approach:', Multiple Sclerosis Journal ISSN 1352-4585 (2020) [Conference Extract]

[eCite] [Details]

Co-authors: Bessing B; Claflin S; Hussain M; Chen J; Blizzard L; van der Mei I

2020Bessing B, Claflin S, Hussain MA, Chen J, Van Dijk P, et al., 'Intra-individual variations in multiple sclerosis symptoms are associated with changes in work productivity of people living with multiple sclerosis', Multiple Sclerosis Journal ISSN 1352-4585 (2020) [Conference Extract]

[eCite] [Details]

Co-authors: Bessing B; Claflin S; Hussain MA; Chen J; van der Mei I

2016Ahmad H, van der Mei I, Taylor B, Palmer AJ, 'PND13 - Assessing Health-State Utility Values in Australian People with Multiple Sclerosis', Value in Health, pp. A875, 19 (7). (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.342 [eCite] [Details]

Co-authors: Ahmad H; van der Mei I; Palmer AJ

Tweet

2016Bostock EC, Kirkby KC, Garry MI, Taylor BVM, 'Comparison of cognitive function in euthymic bipolar disorder and focal epilepsy arising from the temporal lobes: Systematic review', Bipolar Disorders Supplement, 14-17 July, 2016, Amsterdam, Netherlands, pp. 42. ISSN 1399-2406 (2016) [Conference Extract]

DOI: 10.1111/bdi.12407 [eCite] [Details]

Co-authors: Bostock EC; Kirkby KC; Garry MI

Tweet

2016Palmer AJ, Taylor B, Van der Mei I, Si L, Ahmad H, 'CU3 - Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis', Value in Health, pp. A808, 19 (7). (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.722 [eCite] [Details]

Co-authors: Palmer AJ; Van der Mei I; Si L; Ahmad H

Tweet

2015Bostock EC, Kirkby KC, Garry MI, Taylor BVM, 'Overlap of precipitating factors in mania and partial seizures: in pursuit of shared pathophysiology', Bipolar Disorders. Supplement, 3-6 June, 2015, Toronto, Canada, pp. 79. ISSN 1399-2406 (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bostock EC; Kirkby KC; Garry MI

2015Bostock EC, Kirkby KC, Garry MI, Taylor BVM, 'Concurrence of precipitating factors in mania and partial seizures arising from the temporal lobes', Australasian Society for Bipolar and Depressive Disorders Conference, 8-10 November, 2015, Sydney, Australia (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bostock EC; Kirkby KC; Garry MI

2015Landowski LM, Pavez MP, Gasperini RJ, Taylor BVM, West AK, et al., 'Low-density lipoprotein receptor-related proteins guide navigating PNS axons', 2015 PNS Meeting, 28 June - 2 July, 2015, Quebec City, Canada (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Pavez MP; Gasperini RJ; West AK; Foa LC

2015Zhou Y, Zhu GA, Nyholt DR, Charlesworth JC, Simpson JR Steve, et al., 'Multiple Quantitative Trait Loci for Anti-EBNA-1 IgG Titres are Associated with Risk of Multiple Sclerosis', Multiple Sclerosis Journal, pp. 810. ISSN 1352-4585 (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Zhou Y; Zhu GA; Nyholt DR; Charlesworth JC; Simpson JR Steve; Van der Mei IAF

2014Landowski L, Pavez MP, Gasperini R, Taylor BV, West AK, et al., 'LRP receptors in a novel mechanism of axon pathfinding and peripheral nerve regeneration', Proceedings of Neuroscience 2014, 15-19 November 2015, Washington DC (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski L; Pavez MP; Gasperini R; West AK; Foa L

2014Landowski LM, Taylor BVM, West AK, Foa LC, 'Identification of novel neurotrophic-like factors: a candidate for promoting nerve regeneration in neuropathy', ANS Adelaide 2014, Jan 28-31, 2014, Adelaide, Australia (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; West AK; Foa LC

2012Landowski LM, Gasperini RJ, Taylor BVM, West AK, Foa LC, 'Metallothionein I/II induces growth cone chemotaxis via an LRP 1 and LRP 2 dependent mechanism', Neuroscience 2012, 13-17 October, 2012, New Orleans, Louisiana (2012) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Gasperini RJ; West AK; Foa LC

2012Landowski LM, Gasperini RJ, Taylor BVM, West AK, Foa LC, 'Metallothionein I/II induces growth cone chemotaxis via an LRP 1 and LRP 2 dependent mechanism', Neuroscience 2012, 13-17 October, 2012, New Orleans, Louisiana (2012) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Gasperini RJ; West AK; Foa LC

2012Lin R, Perreau V, Glazov E, McMorran B, Bahlo M, et al., 'Searching for rare variants conferring susceptibility to multiple sclerosis', Multiple Sclerosis Journal; Progress in MS Research Conference, 2011, Melbourne, Australia, pp. 701-702; Vol 18. (2012) [Conference Extract]

[eCite] [Details]

Co-authors: McMorran B; Foote S; Charlesworth J; Thomson R; Stankovich J

2011Charlesworth JC, Glahn DC, Curran JE, Kochunov P, Stankovich J, et al., 'Using normal variation in neuroanatomic traits to identify genes and pathways influencing disease: a joint linkage and association analysis of brain lesions', Proceedings of the 8th GeneMappers Conference, 4-6 April 2011, Hotel Grand Chancellor, Hobart, Australia, pp. 56. (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Charlesworth JC; Stankovich J

2011Landowski LM, Gasperini RJ, Small DH, Taylor BVM, West AK, et al., 'Metallothionein I/II and metallothionein III induce growth cone chemotaxis via disparate mechanisms', Australian Neuroscience Society 31st Annual Meeting, 31 Jan - 3 Feb, Auckland, New Zealand (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Landowski LM; Gasperini RJ; Small DH; West AK; Foa LC

2010Lucas RM, Ponsonby AL, Burrows J, Chapman C, Coulthard A, et al., 'Epstein Barr viral infection and onset of central nervous system demyelination', Sage Publications Ltd, June, San Antonio, TX, pp. Vol. 16 (8) 1007. (2010) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF

2010Ponsonby AL, Lucas RM, Van der Mei IAF, Dear K, Taylor BVM, et al., 'Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelination', Sage Publications Ltd, June, San Antonio, TX, pp. Vol 16 (8) p.1007-1008 . (2010) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF

2009van der Walt A, Stankovich J, Bahlo M, Taylor BVM, Van der Mei IAF, et al., 'The HLA-DR2 genotype does not affect MS severity, cognition or brain atrophy', Sage Publications Ltd, 9-12 September, Dusseldorf, Germany, pp. Vol 15 (9) p.183. (2009) [Conference Edited]

[eCite] [Details]

Co-authors: Stankovich J; Van der Mei IAF; Foote SJ

2008Lucas R, Taylor BVM, Ponsonby AL, Chapman C, Coulthard A, et al., 'Latitudinal variation in incidence of first demyclinating events: descriptive analyses of case participants in the Ausimmune Study', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) S190-S191. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF

2008Tremlett H, Van der Mei IAF, Pittas F, Blizzard L, Paley GA, et al., 'Monthly ambient sunlight, vitamin D, infections and relapse rates in multiple sclerosis', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) 203-204. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF; Pittas F; Blizzard L; Paley GA; Meszaros D; Wood-Baker R; Nunez M; Ponsonby AL

2008Van der Mei IAF, Ponsonby AL, Taylor BVM, Stankovich J, Dickinson JL, et al., 'A potentiation of the adverse effect of human leukocyte antigen-DR15 on the risk of multiple sclerosis by low infant sibling exposure: a population based case-control study', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) S201-S202. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF; Stankovich J; Dickinson JL; Foote SJ

2008van der Walt A, Stankovich J, Bahlo M, Taylor BVM, Van der Mei IAF, et al., 'Apolipoprotein E4 genotype does not influence multiple sclerosis phenotype, severity, cognition or brain atrophy in a large Australian cohort', Sage Publications Ltd, 17-20 September, Montreal, Canada, pp. Vol 14 (1) S204. (2008) [Conference Edited]

[eCite] [Details]

Co-authors: Stankovich J; Van der Mei IAF; Foote SJ

2007Tremlett H, Van der Mei IAF, Pittas F, Blizzard L, Paley GA, et al., 'Who's missing out? Pharmionics and the immunomodulatory therapies for MS', Sage Publications, 11-14 October, Prague, Czech Republic, pp. Vol 13 (2) p.S47. (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Van der Mei IAF; Pittas F; Blizzard L; Paley GA

2005Foote SJ, Rubio JP, Bahlo M, Kilpatrick TJ, Speed TP, et al., 'Multiple Sclerosis: a haplotype association study', Novartis Foundation Symposium, 2005, pp. 31-39. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Foote SJ; Stankovich J; Sale MM; Van der Mei IAF; Dickinson JL; Groom PS

2005Jones DL, Pittas F, McInerney G, Rush M, Taylor BV, 'OPL110 Clinical-MRI correlates in multiple sclerosis: Correlation of EDSS, MSFC, fatigue and depression measures with FLAIR, T1 volume and diffusion measures of normal-appearing white matter', Journal of the Neurological Sciences, pp. S74, 238 (Suppl. 1). (2005) [Conference Extract]

DOI: 10.1016/S0022-510X(05)80286-2 [eCite] [Details]

Co-authors: Jones DL; Pittas F

Tweet

2003Van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard CL, Simmons R, et al., 'Past sun exposure, skin phenotype and risk of multiple sclerosis: a case-control study', 15th Conference of the International Society for Environmental Epidemiology, 24-26 September 2003, Perth, Australia (2003) [Conference Extract]

[eCite] [Details]

Co-authors: Van der Mei IAF; Ponsonby AL; Dwyer T; Blizzard CL

1999Jones D, Taylor BV, Coleman D, Williamson JC, Wan P, et al., 'The prevalence of potentialy neuropathic strains of Campylobacter within Tasmania using the Cholera toxin binding assay and pulse-field gel electrophoresis', Poster Display Abstract Booklet, 31st may - 4th June 1999, Royal Hobart Hospital, Hobart, Tasmania, pp. 17. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: McGregor A

1999Taylor BV, Luck JC, Williamson J, Jones D, Coleman D, et al., 'The incidence of antibodies to Campylobacter species in healthy blood donors, patients with previous Campylobacter infections and patients with neurological disease', Poster Display Abstract Booklet, 31st may - 4th June 1999, Royal Hobart Hospital, Hobart, Tasmania, pp. 17-18. (1999) [Conference Extract]

[eCite] [Details]

Co-authors: McGregor A

1997Taylor BV, Kimmel DW, 'The natural history of asymptomatic meningiomas', Programme & Abstracts, Sydney, Australia, pp. 57. (1997) [Conference Extract]

[eCite] [Details]

1997Taylor BV, O'Fallon JR, Buckner J, Cascino TL, 'The effect of radiation therapy on the cognitive performance of high grade glioma patients', Programme & Abstracts, Sydney, Australia, pp. 58. (1997) [Conference Extract]

[eCite] [Details]

1997Taylor BV, Wright RA, Harper CM, Dyck PI, 'Clinical characteristics and longitudinal course of multifocal motor neuropathy with persistent conduction block (MMN-PCB)', Program and Abstracts, Cambridge, England, July 9-12, pp. 236. (1997) [Conference Extract]

[eCite] [Details]

1997Wright RA, Taylor BV, Harper CM, Dyck PJ, 'Electrophysiological characterization of multifocal motor neuropathy (MMN) with persistent motor conduction block (PCB)', Program and Abstracts, Cambridge, England, pp. 103. (1997) [Conference Extract]

[eCite] [Details]

Contract Report, Consultant's Report

(4 outputs)
YearCitationAltmetrics
2023Campbell J, van der Mei I, Taylor B, Palmer A, 'Health Economic Impact of Multiple Sclerosis in Australia in 2021: An Interim Update of Prevalence, Costs and Cost of Illness from 2017 to 2021', Multiple Sclerosis Australia, Hobart, Australia (2023) [Contract Report]

[eCite] [Details]

Co-authors: Campbell J; van der Mei I; Palmer A

2022Chen J, Campbell J, van der Mei I, Bardsley B, Shapland S, et al., 'MS Nurse Care in Australia: Patterns of access and impact on health outcomes', Multiple Sclerosis Australia, Australia (2022) [Contract Report]

[eCite] [Details]

Co-authors: Chen J; Campbell J; van der Mei I

2022Chen Jing, Campbell J, van der Mei I, Bardsley B, Burke T, et al., 'MS Nurse Care in Australia: patterns of access and impact on health outcomes', Multiple Sclerosis Australia, North Sydney NSW (2022) [Contract Report]

[eCite] [Details]

Co-authors: Chen Jing; Campbell J; van der Mei I

2018Ahmad H, Campbell JA, van der Mei I, Taylor B, Palmer AJ, 'Health Economic Impact of Multiple Sclerosis in Australia in 2017: An analysis of MS Research Australia's platform - the Australian MS Longitudinal Study (AMSLS)', Multiple Sclerosis Research Australia (2018) [Contract Report]

[eCite] [Details]

Co-authors: Ahmad H; Campbell JA; van der Mei I; Palmer AJ

Other Public Output

(1 outputs)
YearCitationAltmetrics
2017Ahmad H, Palmer AJ, van der Mei I, Taylor B, 'A sub-group analysis of the Australian Multiple Sclerosis Longitudinal Study (AMSLS) assessing costs and utility in Primary Progressive Multiple Sclerosis (PPMS) patients', Roche Australia, pp. 1-28. (2017) [Government or Industry Research]

[eCite] [Details]

Co-authors: Ahmad H; Palmer AJ; van der Mei I

Grants & Funding

Funding Summary

Number of grants

75

Total funding

$32,339,386

Projects

Understanding MS MOOC extension (2023 - 2025)$324,000
Description
The Understanding MS is a massive open online course designed to educate and raise awareness about multiple sclerosis (MS), improving the lives of people with MS through increased knowledge, self-efficacy, and behaviour change.
Funding
MS Plus ($150,000); Multiple Sclerosis Australia ($174,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2023 - 2025
Pregnancy and Multiple Sclerosis Outcomes (2023 - 2024)$48,750
Description
Retrospective, cross sectional, observational study to evaluate the impact of pregnancy on multiple sclerosis outcomes.
Funding
Monash University ($48,750)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2023 - 2024
Economic Impact report 2023 (2023 - 2025)$184,175
Description
To produce a Report on the Economic Impact of MS in Australia in that:A brief overview of MSPrevalence of MSHealthcare costs and indirect costs (including lost productivity)Quality of life for those affected by MS
Funding
Multiple Sclerosis Australia ($184,175)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Campbell JA; Taylor BVM; Zhao T
Period
2023 - 2025
Evaluating the factors influencing National Disability Insurance Scheme participation and its impact among Australians with MS (2023 - 2025)$244,123
Description
This project will evaluate the roll out of the National Disability Insurance Scheme (NDIS) among Australian living with MS. We will investigate factors associated with NDIS participation and, among participants, NDIS plan value. In order to do this, we will conduct a several studies, including a retrospective cohort study in a representative group of Australians living with MS.
Funding
Multiple Sclerosis Australia ($244,123)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; Claflin SB; van der Mei IAF; Lechner-Scott J; Campbell JA; Graham D
Period
2023 - 2025
Using genomic signatures of natural selection to elucidate the genetic architecture of multiple sclerosis (2023 - 2027)$124,843
Description
Using population data, we will identify genomic loci associated with multiple sclerosis risk that have undergone recent natural selection. We will investigate whether local adaptation at these loci explains the increasing prevalence of MS at higher latitudes. We will identify haplotypes at these loci that occur more often in patients with MS, allowing us to determine specific variation that causes MS. We will use multiple biological datasets to test whether the loci we identify contribute to MS development.
Funding
Multiple Sclerosis Australia ($124,843)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
McComish BJ; Fountain-Jones NM; Taylor BVM; Motyer A; Zhou Y; Melton P
Period
2023 - 2027
A multicentre study of the epidemiology of multiple sclerosis in Australia (2023)$22,430
Description
We have recently described a marked attenuation in the differences in the prevalence and incidence of MS in Hobart, Tasmania compared to studies in Newcastle, NSW conducted similar at similar timepoints. What is unknown is whether this change portends a change in the latitudinal variation of MS across Australia and if so, what factors may be attributable to such a change. The first step of this process is to assess the prevalence and incidence of MS at other sites in Australia and to compare these with Hobart and with one another. In addition to being able to compare between locations, this will have the added benefit of providing prevalence and incidence estimates across three sites on mainland Australia. Should these results indicate a nationwide attenuation in the latitudinal gradient, a follow-on study would recruit people with MS at each site to measure their vitamin D levels and survey their sun and vitamin D-related behaviours to assess whether these factors are driving the changes in the latitudinal gradient of MS frequencies.
Funding
Multiple Sclerosis Australia ($22,430)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Taylor BVM; Simpson-Yap S; Shaw C; Lechner-Scott J; Boggild M; van der Walt A
Year
2023
Unravelling the interplay between EBV genomics and host T cell immune regulation in multiple sclerosis (2023 - 2025)$1,999,237
Description
Epstein Barr Virus (EBV) infects most people in childhood. In some people, it leads to Multiple Sclerosis (MS) but we dont know who or why. This project will evaluate the genetics of people with MS and the EBV in their cells to determine which genetic variants predispose to MS risk and how the immune response varies. We aim to understand the relationship between EBV and human genomes and how it leads to MS to guide future diagnostic, therapeutic, and preventive strategies.
Funding
Medical Research Future Fund ($1,999,237)
Scheme
Grant - Multiple Sclerosis Research
Administered By
University of Tasmania
Research Team
Zhou Y; Smith C; Taylor BVM; Khanna R; Liu J; Engel J; Gratten J; Burdon KP; Blackburn NB; Asthana C; Yang Y
Period
2023 - 2025
A Prospective Investigation of the Feasibility of Smartphone-Based Self-Monitoring to Characterise Cognitive and Neurological Impairment in Patients with Multiple Sclerosis (FLOODLIGHT MS-MOREACTIVE (2022 - 2025)$179,560
Description
The MoreActive Floodlight MS study is a prospective investigation of the feasibility of smartphone based self-monitoring to characterise cognitive and neurological impairment in patients with multiple sclerosis. This study will help in answering the following key research questions: 1. Is there a correlation, both cross-sectional and longitudinal, between the Floodlight MS (FL MS) Cognitive Test digital outcome measures and established clinical and cognitive outcome assessments in patients with multiple sclerosis (pwMS), and can this be characterized into distinct trajectories? 2. Can the digital outcome measures collected with FL MS, MSReactor and Redenlab, together with clinical assessments, predict future disability or cognitive decline in pwMS?
Funding
Monash University ($179,560)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2022 - 2025
Improved monitoring of MS using patient derived and MRI outcomes (2022 - 2023)$32,538
Description
A research study to assess multiple sclerosis outcomes
Funding
Monash University ($32,538)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Smith KA
Period
2022 - 2023
Australian CIDP National Registry: Dissecting Phenotypes and Immunoglobulin Usage Requirements (2022 - 2024)$812,889
Description
This project aims to understand the factors associated with the prescription and use of IVIG (intravenous immunoglobulin) a blood product widely used in Australia to treat a number of chronic neurological conditions. The use of this product is increasing and is putting a significant strain on the health budget and a major driver is use in neurological conditions. Understanding the drivers of starting and the reluctance to cease use of this product can significantly improve the use and effective rationalisation of use which is the principle aim of this project.I will provide expertise on the interpretation and implementation of the data. I have contributed significantly to this work over many years as a member of the Scientific Working Group of the National Blood Authority
Funding
Medical Research Future Fund ($699,290)
Scheme
Grant - Optimising Clinical Use of Immunoglobulins
Administered By
University of Sydney
Research Team
Park S; Taylor BVM
Period
2022 - 2024
Improving outcomes for people with Multiple Sclerosis (2022 - 2026)$2,335,378
Description
MS is the most common cause of non-traumatic neurological disability in young adults, it is a prevalent condition in Australia with more than 25000 cases diagnosed and costs the community>1.7billion dollars annually. I have been at the forefront internationally of discovering the risk factors for development and progression of MS. However there are significant areas in which we have made little progress and consequently MS still presents a major burden to those with the condition, their families and carers, and the community. This proposal will address several important fundamental questions relating to how we study MS by developing an MS STEM cell model that will allow us to study MS in human cells rather than use a rodent model. thus significantly increasing the success rate of discovery translation. Secondly, by advancing our understanding of the genetic architecture of MS (we can at best explain only 25% of MS heritability) will provide significant opportunities to find genes, epigenetic modifications, and pathways that are critical in the development and progression of MS. These discoveries are potential points of intervention for new or repurposed drugs and non pharmacological interventions.. Thirdly the interaction between the genome, the environment, and modifiable lifestyle factors is manifested in changes in 'OMICs' measures including epigenomics, metabolomics, proteomics, and lipidomics developing a large well curated dataset of longitudinal 'OMICS" measures will significantly increase our chances of finding intervention points. Fourthly there exists significant information asymmetry between those with MS and those who care for them I aim to reduce this as well as improve health literacy and resilience and quality of life by utilizing consumer driven initiatives in health education exemplified by my established highly successful MS massive open online Finally I will develop an integrated research translation pipeline to expedite discovery translation.
Funding
National Health & Medical Research Council ($2,335,378)
Scheme
Fellowship-Investigator Grant
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2022 - 2026
Grant Reference
2009389
Improving access to healthcare for Tasmanians living with MS in remote areas (2021)$5,565
Description
This project explores the impact of living in regional and remote areas on access to healthcare and the disability level of Tasmanians with multiple sclerosis.
Funding
Royal Hobart Hospital Research Foundation ($5,565)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Claflin SB; Taylor BVM; Graham D; Giles L
Year
2021
MS Nurses Survey and analysis (2020)$24,118
Description
1.Describe the patterns of access to an MS Nurse of Australians with MS (percentage of access to an MS Nurse overall and by subgroups such as state and remoteness and MS type; reasons no access; frequency that has an MS Nurse as part of their care; provider model; types of access and frequency last 12 months; types of MS Nurse care received)2.Describe the perceived effects of MS Nurse care in terms of adherence to MS treatments, changes to management of MS symptoms and side effects, changes towards a healthier lifestyle, and rating on overall value. 3.Examine whether people with MS who have access to an MS Nurse have better disease outcomes, employment outcomes and enhanced quality of life compared to those not having access to an MS Nurse, and examine whether these differences remain after taking into account personal and clinical characteristics (e.g. education level, onset type). 4.Examine whether people with MS who have access to an MS Nurse have better lifestyle characteristics (e.g. physical activity level), and fewer comorbidities, and examine whether these differences remain after taking into account personal and clinical characteristics (e.g. education level, onset type).
Funding
Multiple Sclerosis Australia ($24,118)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM
Year
2020
Merck Evolution - MS0200527-0080 (2020 - 2025)$734,591
Description
Commercially funded phase III, multicentre, randomised, parallel group, double blind, double dummy, active controlled studyof evobrutinib compared with teriflunomide in participants with relapsing multiple sclerosis to evaluate the efficacy and safety (Double Blind 2 yearsfollowed by open label extension 3 years)
Funding
Merck & Co, Inc ($734,591)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Hussain MA
Period
2020 - 2025
The Menzies Multiple Sclerosis Flagship Program (2020 - 2024)$10,000,000
Description
The Menzies Institute for Medical Research Multiple Sclerosis Flagship Program (MS Flagship) leverages the unique critical mass of MS research in Tasmania connected with Australian MS researchers, collaborators, MS societies and people with MS to address the gaps in the assessment, diagnosis and treatment of MS. Our work builds on our well-developed collaborations and laboratory, epidemiological, health economics and clinical research platforms. Our aim is to improve the clinical management of MS by slowing, halting and even reversing the rate of MS disease progression and to improve the quality of life and reduce the impact that MS has on individuals, their families and society. This project will expand the scope of the MS Flagship program and accelerate discoveries in MS research by supporting five key Activities:1.Establish 'MS Stem' - a stem cell bank specifically designed to advance MS research 2.Gain a better understanding of the regeneration of brain cells and myelin repair 3.Expand our understanding of the rare genetic variation underpinning MS using genome sequencing of MS families and 'MS Stem' cell bank samples4.Develop a treatment economic model which can identify cost-effective treatments and interventions for MS 5.Develop education tools and online resources, including an App specifically for people living with MS
Funding
Medical Research Future Fund ($10,000,000)
Scheme
Grant - Accelerated Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Young K; Charlesworth JC; van der Mei IAF; Palmer AJ
Period
2020 - 2024
InforMS - an electronic patient-driven health care model with digital biomarker monitoring that improves the clinical care of people with MS (2020 - 2025)$1,167,815
Description
Multiple Sclerosis (MS) is a high cost and high burden neurological disease.Problem: there are many disease-modifying therapies available, so clinicians can theoretically switch treatments rapidly based on disease activityand side-effects. Yet this proves difficult when data on these is infrequently collected (currently 1-2 times a year) and is insensitive tofluctuations between visits.Solution: modern computing technologies (mobile apps, wearables) are changing the way health is monitored throughout medicine. We areenabled to collect more data, more accurately, and more frequently, and to share it more easily. If we could effectively harness such newmonitoring technologies for MS, clinicians could be supported with objective, prospectively collected, frequently measured, change-sensitivedata.Proposed research: we will create an electronic patient-centred health care system, InforMS, that becomes a one-stop-shop managementsystem for people with MS. It visualises patient-reported data, allows daily tracking and uploading of data from smartphones and wearablesensors, and allows sharing with clinicians via print, email, third-party access and via MSBase: the most widely used clinician registryworldwide. For clinical care, it would (1) enable timelier changes to treatments, and (2) provide greater confidence that treatments work. Forpatient self care, it would (3) empower people with MS to take a central role in managing their disease, and (4) activate them to collect noveltime-sensitive data. For research, it would (5) deliver powerful annual trend data to enhance MS research. This is a paradigm shift in MS careand research.We already have a prototype of InforMS, developed together with end-users. In this proposal, we will add several key functionalities, roll out thefull InforMS system within a registry of ~3,000 people with MS, and follow participants over time to test and optimise the system in practice.
Funding
National Health & Medical Research Council ($767,815)
Scheme
Grant-Partnership Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Butzkueven H; Taylor BVM; Palmer AJ; Blizzard CL; Nicol D
Period
2020 - 2025
Grant Reference
1193008
Understanding MS MOOC (Massive Open Online Course) (2019 - 2022)$506,000
Description
Developing a massive open online course to improve the overall knowledge of MS in the wider MS community including those living with MS, their families and carers, as well as health care professionals, based on the hypothesis: "Providing current, evidence-based information about MS will increase the knowledge and health literacy of course participants, resulting in improved outcomes for those living with MS and a greater understanding of MS in the general population.
Funding
MS Plus ($306,000); The Select Foundation ($200,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Claflin SB; van der Mei IAF
Period
2019 - 2022
Impact of remoteness on MS outcomes (2019 - 2020)$49,999
Description
*Do people with MS living in regional or remote areas have worse disease outcomes, employment outcomes and quality of life compared to those living in major cities?*How are the costs of MS different for those living in regional or remote areas compared to those living in major cities?*Are any of the above differences explained by personal characteristics (e.g. lower education level), clinical characteristics (e.g. primary progressive onset type), lifestyle characteristics (e.g. lower physical activity level), comorbidities, DMT use, or lack of social support.
Funding
Multiple Sclerosis Australia ($49,999)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Taylor BVM
Period
2019 - 2020
Clinical safety assessment of rTMS application for the treatment of MS (2019)$16,000
Description
Oligodendrocytes are brain cells that die in MS, but non-invasive brain stimulation (rTMS) can promote their generation in preclinical models of disease. This project will take an important role in the clinical translation of this treatment and determine whether this type of stimulation can be safely delivered to people with MS.
Funding
Royal Hobart Hospital Research Foundation ($16,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Cullen CL; Young K; Taylor BVM; Hinder MR
Year
2019
Biomarkers to prevent disability in multiple sclerosis (2019 - 2022)$482,524
Description
Multiple sclerosis (MS) leads to accumulation of irreversible disability predominantly in young adults. Many disease modifying therapies (DMTs) have become available over the last decade; these therapies primarily reduce frequency of MS relapses but can also slow down the accumulation of disability. However, response to DMTs is highly variable and the current management of MS depends on therapeutic trial (and error). Therefore, MS is associated with significant costs (societal and personal) in the form of transient treatment with expensive therapies whose effect in individual patients may be suboptimal, as well as loss of working capacity and consumption of healthcare resources due to the accumulation of permanent disability.In the proposed research, we will address the area of need and generate the key evidence to enable individualised choice of DMTs in patients with MS. First, we will evaluate new and emerging prognostic biomarkers of disease outcomes - serum concentrations of neurofilament light chain, vitamin D and volumetric MRI markers (in particular corpus callosum and deep grey matter atrophy) - in several separate cohorts. We will establish their independent prognostic value in the context of known clinical and demographic prognostic markers. Second, we will establish the combined (additive) prognostic value of these biomarkers and the clinical and demographic information, using a comprehensive predictive model. In particular, we will focus on predicting individual response to treatment prior to treatment start or after the first year of treatment. Applying Bayesian approach to the resulting model, we will build an algorithm to enable prediction of treatment response in individual patients.The project will be completed using MSBase, the largest international observational MS cohort. External validation will be done in collaboration with the Swedish MS Registry, Swiss MS Registry and Czech MS Registry.
Funding
National Health & Medical Research Council ($482,524)
Scheme
Grant-Project
Administered By
Melbourne University Private Ltd
Research Team
Kalincik T; Hadradova E; Kuhle J; Olsen T; Hillert J; Taylor BVM; Malpas C; Kilpatrick T; Barnett M
Period
2019 - 2022
Grant Reference
1157717
Multiple Sclerosis (MS) WorkSmart program: A novel online program to assist people living with MS in the workforce (2018 - 2020)$300,000
Description
Nearly half ($494M) of the total cost of Multiple Sclerosis (MS) ($1.04 billion a year) in Australia is due to sickness absence and early retirement. A large societal cost saving can be made by assisting people with MS to maintain their employment and reduce difficulties associated with their employment. Further, this will have financial benefits for people with MS, as well as improve their overall quality of life. Despite a clear need, there are currently no self-management interventions specifically for people with MS in the workforce. In this project we propose to complete the development and undertake a feasibility study of the MS WorkSmart Program. MS WorkSmart is an online cognitive behaviour therapy self-management program with telephone support accessible on different devices. MS WorkSmart guides a person with MS through six modules over 13-15 weeks, using quizzes, videos and homework activities to assist the learning of strategies that can be applied to their working and daily lives for optimal MS management. The program is being developed together with people with MS and other stakeholders using focus groups and iterative feedback. It is underpinned by cognitive behavioural theory, is embedded in the literature and specifically designed for people with MS who are in the workforce. People will be assisted with telephone-delivered psychological support.
Funding
IOOF Foundation ($300,000)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
van der Mei IAF; Scott JL; de Salas KL; Honan CA; Taylor BVM; Sanderson K; Thomas S; Thomas P
Period
2018 - 2020
VISIONARY-MS A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study for the Treatment of Visual Pathway Deficits In Chronic Optic Neuropathy to Assess the Efficacy, Safety, Tol (2018 - 2021)$116,798
Description
VISIONARY-MS: A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study for the Treatment of Visual Pathway Deficits In Chronic Optic Neuropathy to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of CNM-Au8 For Remyelination In Stable Relapsing-Remitting Multiple Sclerosis (RRMS)
Funding
George Clinical Pty Limited ($116,798)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Bell K; Froelich JJ; MacIntyre J
Period
2018 - 2021
Investigating glutamate transporters in the brain? (2018)$10,186
Description
Too much of a 'good thing' can be bad, especially when it comes to the brain. Glutamate is an important signalling molecule that allows nerves to talk to each other, but it can be toxic if too much is present. The brain has protective machinery in place to move glutamate into cells where it can be detoxified, but if this transport machinery fails, the brain can be damaged. People with multiple sclerosis (MS) have abnormally high levels of glutamate outside of brain cells, both within brain lesions and in seemingly healthy parts of the brain. Dysfunction of the glutamate uptake machinery may be responsible, or at the very least contribute to higher glutamate levels and cause further damage in MS. However, we currently know very little about the levels of the glutamate uptake machinery in healthy people. The main aim of this project will be to examine glutamate uptake machinery in the brains of healthy people, in order to establish appropriate background data so that this information will be available for future studies in MS brain. In addition, I will undertake some studies in mouse brain, to determine if this would be an appropriate model for future MS studies.
Funding
University of Tasmania ($10,186)
Scheme
Grant- Research Enhancement Program
Administered By
University of Tasmania
Research Team
Beasley SJ; Young K; Dickson TC; Charlesworth JC; Taylor BVM
Year
2018
A family-based approach to studying neurodegeneration in multiple sclerosis (2018)$24,928
Description
Multiple sclerosis (MS) is the most common, disabling nervous system disease in young adults. In MS,the immune system attacks the brain and spinal cord, and current treatments act to suppress theimmune system not repair the damage. This project studies the genetics of families with MS todetermine why some people are more susceptible to nerve damage following the immune attack. Weuse whole genome sequencing of all closely related individuals in families, including three of morepeople with MS, and study their genomes to find the genetic differences between affected andunaffected relatives. This work will find new MS risk genes that can be further studied by ourlaboratory-based stem cell biology team using cell-based models of disease. The research willultimately lead to treatments aimed at protecting or repairing the nervous system.
Funding
University of Tasmania ($24,928)
Scheme
Grant- Research Enhancement Program
Administered By
University of Tasmania
Research Team
Charlesworth JC; Young K; Burdon KP; Taylor BVM; McComish BJ
Year
2018
Identifying pathological pathways and putative therapeutics for the treatment of nervous system pathology in people with Multiple Sclerosis (2018 - 2020)$448,999
Description
DNA sequencing of Tasmanian families with multiple closely related MS cases has implicated the GRIK4 gene in the development of this disease. This project aims to understand how GRIK4 affects the central nervous system, determine its role in disease pathogenesis, and repurpose existing pharmaceuticals targeting this pathway to offset neurodegeneration.
Funding
Royal Hobart Hospital Research Foundation ($448,999)
Scheme
Grant-Major Project
Administered By
University of Tasmania
Research Team
Pitman KA; Young K; Taylor BVM; Charlesworth JC; Hewitt A
Period
2018 - 2020
Identifying epigenetic factors involved in MS onset : utilising population-based studies with genetic and environmental measures (2018 - 2020)$851,451
Description
Multiple Sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system (CNS)whose onset is associated with both environmental and genetic factors. These factors likely act, at least in part, through epigenetic alteration, a modifiable mechanism of gene regulation. DNA methylation is a well characterized epigenetic mechanism that can be evaluated at the genome-wide level with the aid of high throughput scanning technologies. Studies of MS patients at disease onset that include epigenetic factors in conjunction with genetic and environmental factors will provide new insights into disease etiology and thus guide better preventive and treatment strategies. This proposal is to undertake a whole epigenomewide study in a multi-site case control study (with replication in other international studies using similarmethods).
Funding
National Multiple Sclerosis Society ($851,451)
Scheme
Grant-Research
Administered By
Australian National University
Research Team
Ponsonby AL; Scott RJ; Lucas R; Lea R; Taylor BVM; Lechner-Scott J; Saffery R; Rubio J; van der Mei IAF
Period
2018 - 2020
Imaging Genetics of Progression in Multiple Sclerosis (2018)$50,000
Description
International study of how genetics influences the progression of multiple sclerosis as measured by MRI
Funding
National Institutes of Health ($50,000)
Scheme
Grant-National Institute of Health
Administered By
University of Tasmania
Research Team
Taylor BVM; Henry R
Year
2018
Adopting a translational research paradigm to prevent or halt neurodegeneration in MS (2018 - 2020)$750,000
Description
This project aims to translate basic neuroscience and genetics discoveries from the bench to the clinic, in order to develop a treatment that can protect the nervous system of patients with Multiple Sclerosis.
Funding
Multiple Sclerosis Australia ($750,000)
Scheme
Fellowship-Macquarie Senior Research/Practitioner
Administered By
University of Tasmania
Research Team
Young K; Taylor BVM
Period
2018 - 2020
The modulation of multiple sclerosis (MS) relapse risk by genetic variations in the LRP2 gene (2018)$24,933
Description
This work will sequence the associated LRP2 gene region to identify the functional variants that modulate MS relapse risk, which is the primary endpoint of many pivotal clinical trials testing the efficacy of MS disease-modifying drugs.
Funding
Royal Hobart Hospital Research Foundation ($24,933)
Scheme
Grant-Minor Project
Administered By
University of Tasmania
Research Team
Zhou Y; Taylor BVM; Charlesworth JC; Burdon KP
Year
2018
inforMS- a new patient-driven health care model for MS (2017 - 2018)$42,750
Description
The project aims:Stage 1: Completion of the inforMS prototype*Data visualisation of existing research data (overview, basic tracking over time (outcomes/medications/behaviours); filtering (comparisons with grouped data).*Patient involvement and feedback*Modify the existing prototype to incorporate the suggested improvements and feedback.Stage 2: Work towards the completion of the full inforMS platform*Plan for the addition of a Data Collection System: This allows patients to enter data in their own time and frequency.Set up the integration with MSBase (an international database operating in over 72 countries, where neurologists continually upload patients' clinical data).
Funding
Multiple Sclerosis Australia ($42,750)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM
Period
2017 - 2018
Economic Impact of MS - 2007 cost of illness data AMSLS - PPMS sub-analysis (2017)$49,379
Description
Based on the published report 'Economic Impact of Multiple Sclerosis in 2010 - Australian MS Longitudinal Study (AMSLS)' Roche is interested in cost and utility data collected from patients with primary progressive multiple sclerosis (PPMS) only.Despite the type of MS not specifically being captured in the 2007 Cost Diary, 39 people with PPMS could be identified by matching participants with a more recent data collection.Roche is seeking Australian, PPMS-specific cost and utility data to inform a PBAC submission lodged in March 2017. A sub-analysis of the data presented in the 2010 report for PPMS patients only was identified as a viable data source to inform the PBAC submission. Objective*PPMS-specific cost and utility data from the 2010 AMSLS analysis (2007 Cost Diary) categorised for applicability in a PBAC submission.*Cost and utility data reported per EDSS*Results available six weeks from the date of the fully signed contract.
Funding
Roche Products Pty Ltd ($49,379)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Taylor BVM
Year
2017
inforMS - a new patient-driven health care model for MS (2017)$28,245
Description
The project aims:Stage 1: Completion of the inforMS prototype*Includes data visualisation of existing research data (overview, basic tracking over time (outcomes/medications/behaviours); filtering (comparisons with grouped data).*Patient involvement and feedbackStage 2: Completion of the full inforMS platform*Add a Data Collection System: This allows patients to enter data in their own time and frequency.*Integration with MSBase (an international database operating in over 72 countries, where neurologists continually upload patients' clinical data).*Perform process evaluation with patients and neurologists/MS nurses to ensure good usability and optimal benefits.
Funding
Multiple Sclerosis Australia ($28,245)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM
Year
2017
Economic Impact of MS in Australia Report (2018) (2017 - 2018)$169,000
Description
*Study to estimate the prevalence of MS in Australia;*Data entry and data cleaning of 2016 AMSLS Cost Diaries;*Analysis of the cost of illness data based on the AMSLS economic impact baseline surveys and cost diaries - the analysis will include both direct and indirect costs of MS.*An analysis of impact on utility/quality of life;*Comparison of results with the 2005 and 2011 Economic Impact reports;*Production of a final presentation Report to include:1.An overview of MS2.Prevalence of MS3.Healthcare costs and indirect costs (including lost productivity)4.Quality of life for those affected by MSProject to be conducted and completed with reference to and in accordance with the 2017 Economic Impact Report Terms of Reference and Merck Grant agreement with MS Research Australia
Funding
Multiple Sclerosis Australia ($169,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Taylor BVM
Period
2017 - 2018
Investigating the anti-inflammatory effect of a non-anticoagulant molecule of heparin following experimental traumatic brain injury (2017)$10,000
Description
Heparin has shown promising results in attenuating neuroinflammation following experimental traumatic brain injury (TBI); however, its anti-coagulative properties make it an unsuitable treatment due to the risk of bleeding. We have recently shown that the heparin derivative Dp4 retains the anti-inflammatory actions of heparin, but not the anti-coagulative properties. In this project, we will test whether Dp4 suppresses neuroinflammation following TBI in mice, potentially identifying it as a novel and valuable therapeutic agent for brain-injured patients.
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Bye N; Taylor BVM; Patel RP
Year
2017
What predicts the progressive phase of multiple sclerosis? (2017 - 2021)$1,791,343
Description
We have made major gains in our understanding of what causes MS. What has proven to be far more difficult is understanding the drivers ofdisability progression and conversion to progressive MS. The onset of progression heralds the accumulation of irreversible disability and is acritical time point to a person with MS. This grant aims to determine the lifestyle, environmental, genetic and epigenetic drivers of MSprogression, using an internationally unique Australian MS longitudinal cohort.
Funding
National Health & Medical Research Council ($1,791,343)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; Scott RJ; van der Mei IAF; Lucas R; Ponsonby AL; Lechner-Scott J; Lea R; Fox A; Broadley SA; Shaw C
Period
2017 - 2021
Grant Reference
1127819
Identifying novel genetic loci associated with an increased relapse rate and disability progression in multiple sclerosis (2017)$10,000
Description
Determining genetic drivers of MS clinical course requires meticulously collected prospective data in well characterised MS longitudinal cohorts. We have such a cohort but lack the comprehensive genotyping to allow this vital analysis. We seek assistance to complete genotyping this cohort
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Zhou Y; Taylor BVM
Year
2017
Generating and characterizing a reliable rodent model type 2 diabetes (2016)$14,673
Funding
University of Tasmania ($14,673)
Scheme
Grant-Research Enhancement (REGS)
Administered By
University of Tasmania
Research Team
Premilovac D; Foa LC; Taylor BVM; Guven N
Year
2016
Does treating multiple sclerosis alter long-term disease outcomes? a natural history study (2016 - 2017)$180,000
Description
A natural history study of MS outcomes between a treated (Australian) versus untreated NZ population to study the long-term effects of MS disease modifying drugs. This is a clinical epidemiological project.
Funding
Multiple Sclerosis Australia ($180,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Palmer AJ; Blizzard CL; Butzkueven H; Simpson Jr S; Kalincik T; Carroll W; Mason D
Period
2016 - 2017
Select Foundation Fellowship - Prof Bruce Taylor (2016 - 2017)$250,000
Description
Relates to Fellowship No. 4
Funding
The Select Foundation ($250,000)
Scheme
Fellowship-Senior Research
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2016 - 2017
Creating an MS Portal to achieve better outcomes for people with MS (2015)$25,000
Description
The project aims to create and test a prototype of a web-based MS Portal that is beneficial for MS patients, health professionals, service delivery organisations and researchers. The project will: 1) conduct surveys and focus groups with stakeholder groups; 2) develop an ethical and logistical framework, and work through practical issues to allow the linkage of specific data sets to occur; 3) trial to set up an enduring linkage between AMSLS and MSBase; 4) design an MS Portal prototype and develop web access protocols; 5) test the MS Portal prototype with all stakeholder groups.
Funding
Multiple Sclerosis Australia ($25,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Stokes BC; Hornsby H; Taylor BVM; Butzkueven H
Year
2015
Promoting regrowth of nerve fibres into the epidermis during diabetic neuropathy by LRP agonists (2015 - 2017)$413,731
Funding
National Health & Medical Research Council ($413,731)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Foa LC; Taylor BVM; West AK; Keske MAV
Period
2015 - 2017
Grant Reference
1088952
DEVA MS: DEvelopment and VAlidation of a cost effectiveness simulation model for Multiple Sclerosis and implications for health policy (2015 - 2016)$160,000
Description
The number of people with multiple sclerosis (MS) is increasing dramatically in Australia, with rapidly escalating associated costs, both direct due to medical expenses and indirect due to lost or reduced employment. Existing and upcoming treatments for MS are expensive, with current prices of up to $25,000 per patient per year and rising. Using the best available data, this study will identify the treatments that are greatest value for money for the most common form of MS (relapsing-remitting MS), with a goal to reduce wastage of limited healthcare resources.
Funding
Multiple Sclerosis Australia ($160,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Palmer AJ; Taylor BVM; van der Mei IAF; Clarke P; Simpson Jr S
Period
2015 - 2016
Development of a therapeutic agent for a chemotherapy-induced neuropathy (2015)$21,739
Description
Chemotherapy-induced neuropathy (CIN) is a dose-limiting side effect of chemotherapy treatment, causing irreversible disability in 40% of cancer survivors. CIN results from the loss or damage of neurons during chemotherapy. We have compelling evidence that the protein metallothionein promotes regeneration of peripheral nerves, and examine its therapeutic use in CIN.This project will create new knowledge in the area of chemotherapy induced neuropathy, and establish the suitability of trophic agents as disease-modifying agents for chemotherapy-induced neuropathy.
Funding
Royal Hobart Hospital Research Foundation ($21,739)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Landowski LM; West AK; Vickers JC; Foa LC; Guven N
Year
2015
Case-control study in Primary Progressive MS: Are the risk factors the same as for people with RRMS onset and can we identify new ones? (2015 - 2016)$142,000
Description
Examining risk factors of disease by comparing cases with a disease to healthy controls has been critical in understanding the aetiology of diseases. In MS, for example, important progress has been made through the epidemiological findings that cases were more likely to have had infectious mononucleosis, have high anti-EBNA IgG titres, and have low sun exposure levels. These findings resulted in a large body of laboratory work focusing on the mechanisms behind these observations. We have previously conducted epidemiological case-control studies on MS, but the number of people with PPMS was always too low to conduct a sub-analysis to examine whether the risk factors that we identified were also important in those with PPMS. We now propose to conduct a case-control of PPMS in a very cost-effective way, by using the data already collected on a large sample of healthy controls (n=558) from the Ausimmune study. We aim to collect the same data from a sample of cases with PPMS in Australia and compare that to the controls of the Ausimmune study. Moreover, the longer-term vision is that this data will form the basis for a prospective longitudinal study, where the cases with PPMS will be followed over time, in order to examine factors that are associated with the progression of MS. This will then be important for identifying possible treatments in MS for people with PPMS. Hypotheses*Established risk factors in MS, including low sun exposure, infectious mononucleosis, smoking, high anti-EBV-EBNA IgG and HLA-DR15 genotype are associated with an increased risk of PPMS onset.*Low parity, lack of younger sibling exposure and exposure to livestock are associated with an increased risk of PPMS.*People with PPMS have a higher EBV DNA load in whole blood and altered EBV serology compared to people with a RRMS onset.
Funding
Multiple Sclerosis Australia ($142,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM; Ponsonby AL; Lucas R; Simpson Jr S; Blizzard CL
Period
2015 - 2016
Australian MS Longitudinal study (2014 - 2024)$1,372,869
Description
The main objectives of this project are: a) to continue the established multi-disciplinary research database for Australia with MS that will provide answers to important questions about the disease that are not able to be addressed by projects funded in the normal, relatively short cycle of research grants; b) to encourage nationwide (and international) multi-disciplinary collaboration on MS research projects, utilising valid and reliable measures that are internationally accepted and compatible wherever possible, and to lead by example in the unification of Australia's efforts to solve the various problems associated with MS; c) to reduce the cost of multi-disciplinary research on MS by provision of a large, well-characterised cohort of volunteer subjects for future studies.
Funding
Multiple Sclerosis Australia ($1,372,869)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM; Palmer AJ
Period
2014 - 2024
Functional consequences of Multiple Sclerosis-associated genetic changes in Vitamin D metabolism genes in T cells and the pathogenesis of autoimmunity (2014 - 2015)$24,950
Description
It is now well recognised that the risk of developing Multiple Sclerosis (MS) is governed by a complex interplay between genetic and environmental factors. Genes within the vitamin D pathway have been implicated in MS risk as has lower levels of vitamin D. How these 2 factors interact to alter immunity and increase the risk of developing autoimmune disease is not clear. This project looks at the functional consequences of a change in the genetic code in known MS risk genes that are in the vitamin D metabolic pathway and how these changes alter the function of T lymphocytes, the immune cells thought to play a major role in the inflammation that is characteristic of MS.
Funding
Multiple Sclerosis Australia ($24,950)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Korner H; Taylor BVM
Period
2014 - 2015
The relationship between Immunoglobulin E (IgE), disease severity and the immune response in multiple sclerosis (2014)$15,300
Description
The immune system in people with multiple sclerosis (MS) is thought to favour inflammatory responses that preclude allergic reactions and the production of the antibody Immunoglobulin E (IgE). This project proposes that IgE levels are in fact high in some people with MS, and that this is protective. It proposes therefore to measure IgE levels in persons with MS and examine associations between IgE, disease severity and immune function.
Funding
Royal Hobart Hospital Research Foundation ($15,300)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Stewart NJ; Simpson Jr S
Year
2014
The role of environmental and genetic factors in progression of multiple sclerosis (2013 - 2016)$945,084
Description
Much is known regarding the factors that increase the risk of developing multiple sclerosis. However there is little data regarding the importance of these and other factors on the rate of progression of MS. Once the diagnosis of MS is made one of the critical issues for patients and treating physicians is; what will happen now? As there are currently no established modifiable risk factors for MS progression, this project aims to delineate potentially modifiable risk factors for MS progression.
Funding
National Health & Medical Research Council ($945,084)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Lucas R; Blizzard CL; Coulthard A; Broadley SA; Williams D; Shaw C
Period
2013 - 2016
Grant Reference
1047180
Examining the role of blood lipids and apolipoproteins on the progression of MS in a prospective clinical cohort (2013)$22,109
Funding
Royal Hobart Hospital Research Foundation ($22,109)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Lucas R; Kostner K; Simpson Jr S
Year
2013
Do metallothioneins promote and direct regenerative growth of epidermal nerve fibres in diabetic peripheral neuropathy? (2013)$33,000
Funding
Brain Foundation ($33,000)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
West AK; Taylor BVM; Foa LC
Year
2013
The Cholecalciferol Intervention to Prevent Respiratory Infections Study (CIPRIS) (2012)$6,335
Funding
The Select Foundation ($6,335)
Scheme
Grant-Small Grants Scheme
Administered By
University of Tasmania
Research Team
Simpson Jr S; Taylor BVM; Stewart NJ; van der Mei IAF; Blizzard CL
Year
2012
A double-blind randomised controlled trial to evaluate the efficacy of 20,000 IU/wk cholecalciferol in reducing respiratory tract infection in a cohort of healthy young adults (2012)$22,256
Funding
Royal Hobart Hospital Research Foundation ($22,256)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Simpson Jr S; van der Mei IAF; Stewart NJ
Year
2012
The effect of vitamin D and Interferon-beta on the immune response (2012)$9,091
Funding
Royal Hobart Hospital Research Foundation ($9,091)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Taylor BVM; Stewart NJ; Simpson Jr S
Year
2012
Environmental and genetic factors that influence the onset and progression of multiple sclerosis (2012 - 2014)$300,000
Funding
Royal Hobart Hospital Research Foundation ($300,000)
Scheme
Fellowship-Research
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2012 - 2014
Examining the role of lipids in the progression of MS in a prospective cohort study (2012 - 2013)$60,000
Funding
Multiple Sclerosis Australia ($60,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM; Blizzard CL; Ponsonby AL; Dwyer T; Kostner K
Period
2012 - 2013
Validating novel serum markers of neurodegeneration in Multiple Sclerosis patients (2010 - 2012)$498,625
Funding
National Health & Medical Research Council ($498,625)
Scheme
Grant-Project
Administered By
University of Melbourne
Research Team
Butzkueven H; Shaw G; Taylor BVM
Period
2010 - 2012
Grant Reference
628799
Identifying rare genetic variants conferring susceptibility to multiple sclerosis (2010 - 2011)$286,350
Funding
National Health & Medical Research Council ($286,350)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Charlesworth JC; Perreau V; Gardiner B; McMorran BJ; Taylor BVM; Browning S
Period
2010 - 2011
Grant Reference
605511
Prognostic factors following a first episode of central nervous system demyelination suggestive of multiple sclerosis (2009 - 2011)$689,575
Funding
National Health & Medical Research Council ($689,575)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Lucas R; Coulthard A; Blizzard CL
Period
2009 - 2011
Grant Reference
544922
Effect of EBV and HHV-6 latent infection or reactivation on MS activity: a prospective clinical cohort study (2008)$258,500
Funding
National Health & Medical Research Council ($258,500)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Ponsonby AL; Taylor BVM; Dwyer D; Dwyer T; Blizzard CL
Year
2008
Grant Reference
490020
New Start Research Fellowship (2007 - 2011)$1,000,000
Funding
University of Tasmania ($1,000,000)
Scheme
Research Fellowship
Administered By
Menzies Research Institute Tasmania
Research Team
Taylor BVM
Period
2007 - 2011
Menzies Research Institute Senior Fellowship Support - Bruce Taylor (2007 - 2009)$180,000
Funding
MS Society of Tasmania ($180,000)
Scheme
Agreement-Fellowship Support
Administered By
University of Tasmania
Research Team
Taylor BVM
Period
2007 - 2009
Identification of Genes that Influence MS Progression by Pathways that Involve UV Exposure: a Prospective Cohort Study (2006 - 2007)$100,000
Funding
Ian Potter Foundation ($100,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
van der Mei IAF; Foote SJ; Dickinson JL; Ponsonby AL; Taylor BVM; Dwyer T; Blizzard CL
Period
2006 - 2007
A National MS Prevalence Study (2005 - 2007)$385,000
Funding
The Health Research Council of New Zealand ($385,000)
Scheme
Project Grant
Administered By
University of Otago, Christchurch School of Medicine
Research Team
Taylor BVM; Richardson A; Sabel C; Mason D; Willoughby E
Period
2005 - 2007
Identification of a Gene that Increases Risk of MS Via a Pathway Involving UV Exposure (2005 - 2006)$109,375
Funding
National Health & Medical Research Council ($109,375)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Dwyer T; McKay JD; Dickinson JL; Ponsonby AL; Taylor BVM; Quinn SJ
Period
2005 - 2006
Grant Reference
333105
The seasonal variation in newly diagnosed MS patients cytokine profiles a case control study (2003)$15,000
Funding
Royal Hobart Hospital Research Foundation ($15,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Stewart N; Walters EH
Year
2003
Correlation of disability, fatigue and depression measures in multiple sclerosis with magnetic resonance imaging measures of lesion load, atrophy and diffusion within normal-appearing white matter (2003)$12,000
Funding
Royal Hobart Hospital Research Foundation ($12,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Jones D; McInerney G; Pittas F; Taylor BVM
Year
2003
The Role of Personal UVR Exposure on the Clinical Course of MS: A Prospective Cohort Study (2003 - 2004)$45,000
Funding
Trish Multiple Sclerosis Research Foundation ($45,000)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Ponsonby AL; Dwyer T; Taylor BVM; van der Mei IAF
Period
2003 - 2004
The Australian Multi-Centre Study of Environment and Immune Function (2003 - 2007)$189,413
Funding
National Multiple Sclerosis Society ($189,413)
Scheme
Grant-Research
Administered By
Australian National University
Research Team
Dwyer T; Ponsonby AL; McMichael T; van der Mei IAF; Dear K; Kilpatrick T; Taylor BVM; Pender M; Williams D
Period
2003 - 2007
The Role of Personal UVR Exposure on the Clinical Course of MS: a Prospective Cohort Study. (2002 - 2004)$378,000
Funding
National Health & Medical Research Council ($378,000)
Scheme
Grant-Project Three Year
Administered By
University of Tasmania
Research Team
Dwyer T; Ponsonby AL; Taylor BVM; Gies P; McMichael T
Period
2002 - 2004
Grant Reference
211308
The Tasmanian Epilepsy Register Health Study (2002)$11,364
Funding
Royal Hobart Hospital Research Foundation ($11,364)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Dwyer T; D'Souza WJ; Taylor BVM
Year
2002
The role of pro and anti inflammatory cytokines in the progression of multiple sclerosis and the occurrence of relapses of multiple sclerosis and the relationships of cytokine profiles in MS patients to environmental UV exposure and vitamin D metabol (2001)$10,000
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylov BVM; Pittas F; Walters EH
Year
2001
Campylobacter project (2001)$17,000
Funding
Royal Hobart Hospital Research Foundation ($17,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Jones D; Coleman D; Williamson J; McGregor A
Year
2001
Assessment of the cross reactivity between anti campylobacter antibodies and anti ganglioside antibodies in human neuropathic disorders. (2000)$10,000
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Williamson J; Luck J
Year
2000
Can infection with campylobacter species cause asymptomatic GBS (1999)$3,500
Funding
Royal Hobart Hospital Research Foundation ($3,500)
Scheme
Project Grant
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM; Jones D; Coleman D; Williamson J; McGregor A
Year
1999
Campylobacteriosis in Tasmania (1998 - 2000)$150,000
Funding
Department of Coummunity & Health Services Tasmania ($150,000)
Scheme
The Dick Buttfield Memorial Fellowship
Administered By
Royal Hobart Hospital
Research Team
Taylor BVM
Period
1998 - 2000

Research Supervision

Current

7

Completed

19

Current

DegreeTitleCommenced
PhDLong-term Trajectories of Disability and Employment Outcomes in People with Multiple Sclerosis2019
PhDIdentifying Genetic and Molecular Signatures of Multiple Sclerosis Onset and Progression2020
PhDUnderstanding Employment and Assisting People with MS with Employment Through MS WorkSmart2020
PhDThe Health Economics of Multiple Sclerosis in Australia: a detailed investigation of health-related quality of life and costs for applied policy and decision making2021
PhDUnderstanding the Impact of Pain on People with Multiple Sclerosis2022
PhDAssessing feasibility of an Australian Multiple Sclerosis Carers Study (AMS-Carers): Mitigating the burden of caring to Improve the lives of people with MS and their support network2022
PhDA Multi-omics Study of Multiple Sclerosis: using multi-omics to discover prognostic biomarkers for MS onset and progression & understanding MS risk via Epstein-Barr virus genomics2023

Completed

DegreeTitleCompleted
PhDGenetic and Environmental Determinants Involved in the Onset and Progression of Multiple Sclerosis
Candidate: Valery Fuh Ngwa		2023
PhDLow Intensity Repetitive Transcranial Magnetic Stimulation Promotes Myelin Repair by Surviving and New Oligodendrocytes
Candidate: Phuong Tram Nguyen		2023
PhDWork Productivity and Education in Multiple Sclerosis
Candidate: Barnabas Bessing		2023
PhDThe Role of Diet in Multiple Sclerosis
Candidate: Alice Margaret Saul		2023
PhDHealth-Economic Consequences of Multiple Sclerosis in Australia
Candidate: Hasnat Ahmad		2021
PhDUnderstanding the Prevalence and Impact of Comorbidities on People with Multiple Sclerosis
Candidate: Lara Marie Pangan Lo		2021
PhDBetter Understanding of Progressive Multiple Sclerosis
Candidate: Yan Zhang		2020
PhDImproving Employment Outcomes for People with Multiple Sclerosis
Candidate: Jing Chen		2020
PhDLRP1 is a Negative Regulator of Oligodendrogenesis in the Adult Mouse Central Nervous System
Candidate: Loic Francis Auderset		2020
PhDUnderstanding Mania in Bipolar Disorder: Perspectives on causation and pathogenesis
Candidate: Emmanuelle Charlotte Sophie Bostock		2019
PhDNew Evidence for an Association between Immune Cells, Vitamin D and MS Risk SNPs
Candidate: Ming Lu		2019
PhDAssociations Between Environmental or Behavioural Factors and Natural History of MS
Candidate: Chunrong Tao		2018
MastersOn the Role of Risk-Associated Genetic Loci in Modulating Clinical Course in Multiple Sclerosis
Candidate: Gongbu Pan		2016
PhDIdentifying Genetic Variants and Environmental Factors Influencing Multiple Sclerosis Pathological Processes
Candidate: Yuan Zhou		2016
PhDThe Role of Serum Lipid Profile and Comorbidities in the Onset and Progression of Multiple Sclerosis
Candidate: Prudence Tettey		2016
PhDLRP Receptors in a Novel Mechanism of Axon Pathfinding and Peripheral Nerve Regeneration
Candidate: Lila Maree Landowski		2014
PhDDissecting the Genetics Architecture of Multiple Sclerosis
Candidate: Rui Lin		2014
PhDOn the Geoepidemiology of Multiple Sclerosis and Environmental and Infectious Determinants of its Clinical Course
Candidate: Steve Lee Simpson Jr		2011
PhDLongitudinal Study of Multiple Sclerosis in Southern Tasmania: Description of Cohort and Impact of Demographic, Disease, Individual and Lifestyle Factors on Clinical Multiple Sclerosis Disability and Progression
Candidate: Fotini Pittas		2009